Healthcare Realty Trust (HR) 10-Q 8 Aug 23 2023 Q2 Quarterly report Financial data

Cover Page

Cover Page - shares	6 Months Ended
	Jun. 30, 2023	Aug. 04, 2023
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2023
Document Transition Report	false
Entity File Number	001-35568
Entity Registrant Name	HEALTHCARE REALTY TRUST INCORPORATED
Entity Incorporation, State or Country Code	MD
Entity Tax Identification Number	20-4738467
Entity Address, Address Line One	3310 West End Avenue
Entity Address, Address Line Two	Suite 700
Entity Address, City or Town	Nashville
Entity Address, State or Province	TN
Entity Address, Postal Zip Code	37203
City Area Code	615
Local Phone Number	269-8175
Title of 12(b) Security	Class A Common Stock, $0.01 par value per share
Trading Symbol	HR
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Large Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		380,857,532
Entity Central Index Key	0001360604
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q2
Amendment Flag	false

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Real estate properties
Land	$ 1,424,453	$ 1,439,798
Buildings and improvements	11,188,821	11,332,037
Lease intangibles	922,029	959,998
Personal property	12,615	11,907
Investment in financing receivable, net	121,315	120,236
Financing lease right-of-use assets	83,016	83,824
Construction in progress	53,311	35,560
Land held for development	78,411	74,265
Total real estate properties	13,883,971	14,057,625
Less accumulated depreciation and amortization	(1,983,944)	(1,645,271)
Total real estate properties, net	11,900,027	12,412,354
Cash and cash equivalents	35,904	60,961
Assets held for sale, net	151	18,893
Operating lease right-of-use assets	333,224	336,983
Investments in unconsolidated joint ventures	327,245	327,248
Goodwill	250,530	223,202
Other assets, net	547,266	469,990
Total assets	13,394,347	13,849,631
Liabilities
Notes and bonds payable	5,340,272	5,351,827
Accounts payable and accrued liabilities	196,147	244,033
Liabilities of assets held for sale	222	437
Operating lease liabilities	278,479	279,895
Financing lease liabilities	73,629	72,939
Other liabilities	219,694	218,668
Total liabilities	6,108,443	6,167,799
Commitments and contingencies
Redeemable non-controlling interests	2,487	2,014
Stockholders' equity
Preferred stock, $.01 par value per share; 200,000 shares authorized; none issued and outstanding	0	0
Class A Common stock, $.01 par value per share; 1,000,000 shares authorized; 380,858 and 380,590 shares issued and outstanding at June 30, 2023 and December 31, 2022, respectively	3,808	3,806
Additional paid-in capital	9,595,033	9,587,637
Accumulated other comprehensive (loss) income	9,328	2,140
Cumulative net income attributable to common stockholders	1,137,171	1,307,055
Cumulative dividends	(3,565,941)	(3,329,562)
Total stockholders' equity	7,179,399	7,571,076
Non-controlling interest	104,018	108,742
Total equity	7,283,417	7,679,818
Total liabilities and equity	$ 13,394,347	$ 13,849,631

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2023	Dec. 31, 2022
Statement of Financial Position [Abstract]
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, authorized (in shares)	200,000,000	200,000,000
Preferred stock, issued (in shares)	0	0
Preferred stock, outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, authorized (in shares)	1,000,000,000	1,000,000,000
Common stock, issued (in shares)	380,858,000	380,590,000
Common stock, outstanding (in shares)	380,858,000	380,590,000

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Revenues
Rental income	$ 329,680	$ 140,632	$ 653,773	$ 279,121
Interest income	4,233	1,957	8,448	3,887
Other operating	4,230	2,738	8,847	5,213
Revenues	338,143	145,327	671,068	288,221
Expenses
Property operating	125,395	57,010	247,436	114,474
General and administrative	15,464	10,540	30,399	21,576
Acquisition and pursuit costs	669	1,352	956	2,655
Merger-related costs	(15,670)	7,085	(10,815)	13,201
Depreciation and amortization	183,193	55,731	367,671	109,772
Expenses	309,051	131,718	635,647	261,678
Other income (expense)
Gain on sales of real estate properties	7,156	8,496	8,162	53,280
Interest expense	(65,334)	(15,543)	(129,092)	(29,204)
Loss on extinguishment of debt	0	0	0	(1,429)
Impairment of real estate properties and credit loss reserves	(55,215)	0	(86,637)	25
Equity loss from unconsolidated joint ventures	(17)	(307)	(797)	(652)
Interest and other income (expense), net	592	(125)	1,139	(206)
Total other income (expense)	(112,818)	(7,479)	(207,225)	21,814
Net (loss) income	(83,726)	6,130	(171,804)	48,357
Net loss attributable to non-controlling interests	967	0	1,920	0
Net (loss) income attributable to common stockholders	$ (82,759)	$ 6,130	$ (169,884)	$ 48,357
Basic earnings per common share (in dollars per share)	$ (0.22)	$ 0.04	$ (0.45)	$ 0.32
Diluted earnings per common share (in dollars per share)	$ (0.22)	$ 0.04	$ (0.45)	$ 0.32
Weighted average common shares outstanding - basic (in shares)	378,896,677	149,675,855	378,860,631	149,321,412
Weighted average common shares outstanding - diluted (in shares)	378,896,677	149,738,549	378,860,631	149,396,806
Revenue, Product and Service [Extensible List]	Service [Member]	Service [Member]	Service [Member]	Service [Member]

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Comprehensive Income - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Net (loss) income	$ (83,726)	$ 6,130	$ (171,804)	$ 48,357
Interest rate swaps
Reclassification adjustments for (gains) losses included in net income (interest expense)	(3,419)	823	(5,703)	1,909
Gains arising during the period on interest rate swaps	21,523	1,663	12,981	6,822
Other comprehensive income	18,104	2,486	7,278	8,731
Comprehensive (loss) income	(65,622)	8,616	(164,526)	57,088
Less: comprehensive loss attributable to non-controlling interests	745	0	1,830	0
Comprehensive (loss) income attributable to common stockholders	(64,877)	8,616	(162,696)	57,088
Interest Rate Swaps
Interest rate swaps
Gains arising during the period on interest rate swaps	$ 21,523	$ 1,663	$ 12,981	$ 6,822

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Equity - USD ($) $ in Thousands	Total	Total Stockholders’ Equity	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Income (Loss)	Cumulative Net Income	Cumulative Dividends	Non-controlling Interests
Beginning balance at Dec. 31, 2021	$ 2,185,116	$ 2,185,116	$ 1,505	$ 3,972,917	$ (9,981)	$ 1,266,158	$ (3,045,483)	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs	22,771	22,771	7	22,764
Common stock redemptions	(206)	(206)		(206)
Share-based compensation	7,055	7,055	4	7,051
Net (loss) income	48,357	48,357				48,357
Reclassification adjustments for gains included in net income (interest expense)	1,909	1,909			1,909
Gains arising during the period on interest rate swaps	6,822	6,822			6,822
Dividends to common stockholders and distributions to non-controlling interest holders	(93,957)	(93,957)					(93,957)
Ending balance at Jun. 30, 2022	2,177,867	2,177,867	1,516	4,002,526	(1,250)	1,314,515	(3,139,440)	0
Redeemable Non-controlling Interests, beginning balance at Dec. 31, 2021	0
Redeemable Non-controlling Interests, ending balance at Jun. 30, 2022	0
Beginning balance at Mar. 31, 2022	2,212,882	2,212,882	1,516	3,999,060	(3,736)	1,308,385	(3,092,343)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs	110	110		110
Share-based compensation	3,356	3,356		3,356
Net (loss) income	6,130	6,130				6,130
Reclassification adjustments for gains included in net income (interest expense)	823	823			823
Gains arising during the period on interest rate swaps	1,663	1,663			1,663
Dividends to common stockholders and distributions to non-controlling interest holders	(47,097)	(47,097)					(47,097)
Ending balance at Jun. 30, 2022	2,177,867	2,177,867	1,516	4,002,526	(1,250)	1,314,515	(3,139,440)	0
Redeemable Non-controlling Interests, beginning balance at Mar. 31, 2022	0
Redeemable Non-controlling Interests, ending balance at Jun. 30, 2022	0
Beginning balance at Dec. 31, 2022	7,679,818	7,571,076	3,806	9,587,637	2,140	1,307,055	(3,329,562)	108,742
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs	78	78		78
Common stock redemptions	(1,596)	(1,596)	(1)	(1,595)
Share-based compensation	8,916	8,916	3	8,913
Net (loss) income	(171,804)	(169,884)				(169,884)		(1,920)
Reclassification adjustments for gains included in net income (interest expense)	(5,703)	(5,635)			(5,635)			(68)
Gains arising during the period on interest rate swaps	12,981	12,823			12,823			158
Dividends to common stockholders and distributions to non-controlling interest holders	(239,273)	(236,379)					(236,379)	(2,894)
Ending balance at Jun. 30, 2023	7,283,417	7,179,399	3,808	9,595,033	9,328	1,137,171	(3,565,941)	104,018
Redeemable Non-controlling Interests, beginning balance at Dec. 31, 2022	2,014
Redeemable Non-controlling Interests
Contributions from non-controlling interests	473
Redeemable Non-controlling Interests, ending balance at Jun. 30, 2023	2,487
Beginning balance at Mar. 31, 2023	7,464,839	7,358,628	3,808	9,591,194	(8,554)	1,219,930	(3,447,750)	106,211
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock, net of issuance costs	27	27		27
Common stock redemptions	(112)	(112)		(112)
Share-based compensation	3,924	3,924		3,924
Net (loss) income	(83,726)	(82,759)				(82,759)		(967)
Reclassification adjustments for gains included in net income (interest expense)	(3,419)	(3,377)			(3,377)			(42)
Gains arising during the period on interest rate swaps	21,523	21,259			21,259			264
Dividends to common stockholders and distributions to non-controlling interest holders	(119,639)	(118,191)					(118,191)	(1,448)
Ending balance at Jun. 30, 2023	7,283,417	$ 7,179,399	$ 3,808	$ 9,595,033	$ 9,328	$ 1,137,171	$ (3,565,941)	$ 104,018
Redeemable Non-controlling Interests, beginning balance at Mar. 31, 2023	2,000
Redeemable Non-controlling Interests
Contributions from non-controlling interests	487
Redeemable Non-controlling Interests, ending balance at Jun. 30, 2023	$ 2,487

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Equity (Parenthetical) - $ / shares	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Statement of Stockholders' Equity [Abstract]
Dividends to common stockholders (in dollars per share)	$ 0.31	$ 0.31	$ 0.62	$ 0.62

Condensed Consolidated Statem_5

Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022
OPERATING ACTIVITIES
Net (loss) income	$ (171,804)	$ 48,357
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	367,671	109,772
Other amortization	23,405	2,680
Share-based compensation	8,916	7,055
Amortization of straight-line rent receivable (lessor)	(19,313)	(3,292)
Amortization of straight-line rent on operating leases (lessee)	3,062	756
Gain on sales of real estate properties	(8,162)	(53,280)
Loss on extinguishment of debt	0	1,429
Impairment of real estate properties and credit loss reserves	86,637	(25)
Equity loss from unconsolidated joint ventures	797	652
Distributions from unconsolidated joint ventures	3,031	108
Non-cash interest from financing and notes receivable	(488)	(388)
Changes in operating assets and liabilities:
Other assets, including right-of-use-assets	(17,502)	540
Accounts payable and accrued liabilities	(38,601)	(3,166)
Other liabilities	16,673	2,923
Net cash provided by operating activities	254,322	114,121
INVESTING ACTIVITIES
Acquisitions of real estate	(39,301)	(287,004)
Development of real estate	(17,594)	(7,475)
Additional long-lived assets	(94,013)	(45,631)
Funding of mortgages and notes receivable	(11,503)	0
Investments in unconsolidated joint ventures	(3,824)	(49,599)
Investment in financing receivable	(780)
Investment in financing receivable		498
Proceeds from sales of real estate properties and additional long-lived assets	160,870	108,044
Net cash used in investing activities	(6,145)	(281,167)
FINANCING ACTIVITIES
Net (repayments) borrowings on unsecured credit facility	(31,000)	280,500
Repayments of notes and bonds payable	(1,340)	(18,224)
Redemption of notes and bonds payable	0	(2,184)
Dividends paid	(236,105)	(93,774)
Net proceeds from issuance of common stock	77	22,768
Common stock redemptions	(1,842)	(852)
Distributions to non-controlling interest holders	(2,546)	0
Debt issuance and assumption costs	(438)	0
Payments made on finance leases	(40)	(51)
Net cash (used in) provided by financing activities	(273,234)	188,183
(Decrease) increase in cash and cash equivalents	(25,057)	21,137
Cash and cash equivalents at beginning of period	60,961	13,175
Cash and cash equivalents at end of period	35,904	34,312
Supplemental Cash Flow Information
Interest paid	106,985	26,641
Mortgage note receivable taken in connection with sale of real estate	45,000	0
Invoices accrued for construction, tenant improvements and other capitalized costs	30,956	18,874
Capitalized interest	$ 1,282	$ 145

Summary of Significant Accounti

Summary of Significant Accounting Policies	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Business Overview Healthcare Realty Trust Incorporated is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of June 30, 2023, the Company had gross investments of approximately $13.9 billion in 680 wholly-owned real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property. The Company's 680 real estate properties are located in 35 states and total approximately 39.8 million square feet. The Company provided leasing and property management services to approximately 39.3 million square feet nationwide. In addition, as of June 30, 2023, the Company had a weighted average ownership interest of approximately 44% in 34 real estate properties held in joint ventures. See Note 3 below for more details regarding the Company's unconsolidated joint ventures. Any references to square footage or occupancy percentage, and any amounts derived from these values in these notes to the Company's Condensed Consolidated Financial Statements, are outside the scope of our independent registered public accounting firm’s review. Basis of Presentation For purposes of this Quarterly Report on Form 10-Q, references to the “Company” are to Legacy HR for periods prior to the closing of the Merger and thereafter to Legacy HR and Legacy HTA as the combined company after giving effect to the Merger. The Merger is described in more detail in Note 2 to these Condensed Consolidated Financial Statements. The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. However, except as disclosed herein and specific disclosures included as a result of the Merger, management believes there has been no material change in the information disclosed in the Notes to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2022. All material intercompany transactions and balances have been eliminated in consolidation. This interim financial information should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2023 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties. Principles of Consolidation The Company’s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). Accounting Standards Codification (“ASC”) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity’s economic performance or (ii) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE’s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity’s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis. For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities’ activities based upon the terms of the respective entities’ ownership agreements. Healthcare Realty Holdings, L.P., a Delaware limited partnership (the "OP"), is 98.8% owned by the Company. Holders of operating partnership units (“OP Units”) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of June 30, 2023, there were approximately 4.7 million OP Units, or 1.2% of OP units issued and outstanding, held by non-controlling interest holders. Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates the interests in the OP. As of June 30, 2023, the Company had four consolidated VIEs in addition to the OP where it is the primary beneficiary of the VIE based on the combination of operational control and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures. Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate: (dollars in thousands) JUNE 30, 2023 Assets: Net real estate investments $ 61,980 Cash and cash equivalents 2,107 Receivables and other assets 2,015 Total assets $ 66,102 Liabilities: Accrued expenses and other liabilities $ 14,058 Total equity 52,044 Total liabilities and equity $ 66,102 As of June 30, 2023, the Company had three unconsolidated VIEs consisting of two notes receivables and one joint venture. The Company does not have the power or economic interests to direct the activities of the VIEs on a stand-alone basis, and therefore it was determined that the Company was not the primary beneficiary. As a result, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method. See below for additional information regarding the Company's unconsolidated VIEs. (dollars in thousands) ORIGINATION DATE LOCATION SOURCE CARRYING AMOUNT MAXIMUM EXPOSURE TO LOSS 2021 Houston, TX 1 Note receivable $ 30,445 $ 31,150 2021 Charlotte, NC 1 Note receivable 5,691 6,000 2022 Texas 2 Joint venture 64,758 64,758 1 Assumed mortgage note receivable in connection with the Merger. 2 Includes investments in seven properties. As of June 30, 2023, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities. See Note 3 below for more details regarding the Company's unconsolidated joint ventures. Use of Estimates in the Condensed Consolidated Financial Statements Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates. Reclassifications Certain reclassifications have been made on the Company's prior year Condensed Consolidated Balance Sheet to conform to current year presentation. Previously, the Company's Lease intangibles were included in Building, improvements and lease intangibles and Goodwill was included with Other assets, net. These amounts are now classified as separate line items on the Company's Condensed Consolidated Balance Sheets. Redeemable Non-Controlling Interests The Company accounts for redeemable equity securities in accordance with ASC Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders’ equity. The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheets. Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest’s share of net income or loss and distributions) or the redemption value. We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest. As of June 30, 2023, the Company had redeemable non-controlling interests of $2.5 million. Asset Impairment The Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever the occurrence of an event or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company’s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its tenants. During the three and six months ended June 30, 2023, the Company recognized real estate impairments totaling $55.2 million and $81.4 million, respectively, as a result of completed or planned disposition activity. Investments in Leases - Financing Receivables, Net In accordance with ASC Topic 842: Leases, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC Topic 310: Receivables. See below for additional information regarding the Company's financing receivables. (dollars in thousands) ORIGINATION DATE LOCATION INTEREST RATE CARRYING VALUE as of JUNE 30, 2023 May 2021 Poway, CA 5.73% $ 113,967 November 2021 Columbus, OH 6.48% 7,348 $ 121,315 Real Estate Notes Receivable Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower’s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held-to-maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses. As of June 30, 2023, real estate notes receivable, net, which are included in Other assets on the Company's Condensed Consolidated Balance Sheets, totaled $151.5 million. (dollars in thousands) ORIGINATION MATURITY STATED INTEREST RATE MAXIMUM LOAN COMMITMENT OUTSTANDING as of ALLOWANCE FOR CREDIT LOSSES FAIR VALUE DISCOUNT AND FEES CARRYING VALUE as of JUNE 30, 2023 Mezzanine loans Texas 6/24/2021 6/24/2024 8.00 % $ 54,119 $ 54,119 $ (5,196) $ (3,067) $ 45,856 Mortgage loans Texas 6/30/2021 12/31/2023 7.00 % 31,150 31,150 — (705) 30,445 North Carolina 12/22/2021 12/22/2024 8.00 % 6,000 6,000 — (309) 5,691 Florida 5/17/2022 2/27/2026 6.00 % 65,000 24,556 — (55) 24,501 California 3/30/2023 3/29/2026 6.00 % 45,000 45,000 — — 45,000 147,150 106,706 — (1,069) 105,637 $ 201,269 $ 160,825 $ (5,196) $ (4,136) $ 151,493 Allowance for Credit Losses Pursuant to ASC Topic 326, Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under ASC Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company’s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. In its assessment of current expected credit losses for real estate notes receivable, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each note to estimate a probability of default and a resulting loss for each real estate note receivable. During the six months ended June 30, 2023, the Company determined that the risk of credit loss on its mezzanine loans was no longer remote. Consequently, the Company recorded a credit loss reserve of $5.2 million for the six months ended June 30, 2023. The following table summarizes the Company's allowance for credit losses on real estate notes receivable: Dollars in thousands June 30, 2023 December 31, 2022 Allowance for credit losses, beginning of period $ — $ — Credit loss reserves 5,196 — Allowance for credit losses, end of period $ 5,196 $ — Interest Income Income from Lease Financing Receivables The Company recognized the related income from two financing receivables totaling $2.1 million and $4.2 million, respectively, for the three and six months ended June 30, 2023, and $2.0 million and $3.9 million, respectively for the three and six months ended June 30, 2022, based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable in any particular period will not equal the cash payments from the lease agreement in that period. Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Income from financing receivable, net over the life of the lease. Income from Real Estate Notes Receivable During the three and six months ended June 30, 2023, the Company recognized interest income of $2.2 million and $4.3 million, respectively, related to real estate notes receivable. The Company recognizes interest income on an accrual basis unless the Company has determined that collectability of contractual amounts is not reasonably assured, at which point the note is placed on non-accrual status and interest income is recognized on a cash basis. As of June 30, 2023, the Company placed two of its real estate notes receivable with principal balances of $48.9 million on non-accrual status and accordingly did not recognize any interest income for the three and six month periods ended June 30, 2023. Revenue from Contracts with Customers (ASC Topic 606) The Company recognizes certain revenue under the core principle of Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five step model specified in the guidance. Revenue that is accounted for under Topic 606 is segregated on the Company’s Condensed Consolidated Statements of Operations in the Other operating line item. This line item includes parking income, management fee income and other miscellaneous income. Below is a detail of the amounts by category: THREE MONTHS ENDED SIX MONTHS ENDED in thousands 2023 2022 2023 2022 Type of Revenue Parking income $ 2,370 $ 1,919 $ 4,761 $ 3,672 Management fee income 1 1,597 783 3,570 1,438 Miscellaneous 263 36 516 103 $ 4,230 $ 2,738 $ 8,847 $ 5,213 1 Includes the recovery of certain expenses under the financing receivable as outlined in the management agreement. The Company’s major types of revenue that are accounted for under Topic 606 that are listed above are all accounted for as the performance obligation is satisfied. The performance obligations that are identified for each of these items are satisfied over time, and the Company recognizes revenue monthly based on this principle.

Merger with HTA

Merger with HTA	6 Months Ended
	Jun. 30, 2023
Business Combination and Asset Acquisition [Abstract]
Merger with HTA	Merger with HTA On July 20, 2022 (the “Closing Date”), pursuant to the Agreement and Plan of Merger dated as of February 28, 2022 (the “Merger Agreement”), by and among Healthcare Realty Trust Incorporated, a Maryland corporation (now known as HRTI, LLC, a Maryland limited liability company) (“Legacy HR”), Healthcare Trust of America, Inc., a Maryland corporation (now known as Healthcare Realty Trust Incorporated) (“Legacy HTA”), the OP, and HR Acquisition 2, LLC, a Maryland limited liability company (“Merger Sub”), Merger Sub merged with and into Legacy HR, with Legacy HR continuing as the surviving entity and a wholly-owned subsidiary of Legacy HTA (the “Merger”). On the Closing Date, each outstanding share of Legacy HR common stock, $0.01 par value per share (the “Legacy HR Common Stock”), was cancelled and converted into the right to receive one share of Legacy HTA class A common stock at a fixed ratio of 1.00 to 1.00. Per the terms of the Merger Agreement, Legacy HTA declared a special dividend of $4.82 (the “Special Dividend”) for each outstanding share of Legacy HTA class A common stock, $0.01 par value per share ( the “Legacy HTA Common Stock”), and the OP declared a corresponding distribution to the holders of its partnership units, payable to Legacy HTA stockholders and OP unitholders of record on July 19, 2022. Immediately following the Merger, Legacy HR converted to a Maryland limited liability company and changed its name to HRTI, LLC and Legacy HTA changed its name to “Healthcare Realty Trust Incorporated”. In addition, the equity interests of Legacy HR were contributed by Legacy HTA by means of a contribution and assignment agreement to the OP, and Legacy HR became a wholly-owned subsidiary of the OP. The Company operates under the name “Healthcare Realty Trust Incorporated” and its shares of class A common stock, $0.01 par value per share, trade on the New York Stock Exchange under the ticker symbol “HR”. For accounting purposes, the Merger was treated as a “reverse acquisition” in which Legacy HTA was considered the legal acquirer and Legacy HR was considered the accounting acquirer based on various factors, including, but not limited to: (i) the composition of the board of directors of the combined company following the Merger, (ii) the composition of senior management of the combined company following the Merger, and (iii) the premium transferred to the Legacy HTA stockholders. As a result, the historical financial statements of the accounting acquirer, Legacy HR, became the historical financial statements of the Company. The acquisition was accounted for using the acquisition method of accounting in accordance with ASC 805, Business Combinations, which requires, among other things, the assets acquired and the liabilities assumed and non-controlling interests, if any, to be recognized at their acquisition date fair value. The implied consideration transferred on the Closing Date is as follows: Dollars in thousands, except for per share data Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (a) 228,520,990 Exchange ratio 1.00 Implied shares of Legacy HR Common Stock issued 228,520,990 Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (b) $ 24.37 Value of implied Legacy HR Common Stock issued $ 5,569,057 Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services (c) 7,406 Consideration transferred $ 5,576,463 (a) The number of shares of Legacy HTA Common Stock presented above was based on 228,857,717 total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less 192 Legacy HTA fractional shares that were cancelled in lieu of cash and less 336,535 shares of Legacy HTA restricted stock (net of 215,764 shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares were converted to Legacy HR Common Stock, at an exchange ratio of 1.00 share of Legacy HR Common Stock per share of Legacy HTA Common Stock. (b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022. (c) Represents the fair value of Legacy HTA restricted shares which fully vested prior to the closing of the Merger or became fully vested as a result of the closing of the Merger and which are attributable to pre-combination services. Preliminary Purchase Price Allocation The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed at the Closing Date: Dollars in thousands PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE CUMULATIVE MEASUREMENT PERIOD ADJUSTMENTS PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE ASSETS Real estate investments Land $ 985,926 $ 18,359 $ 1,004,285 Buildings and improvements 6,960,418 (119,135) 6,841,283 Lease intangible assets (a) 831,920 1,839 833,759 Financing lease right-of-use assets 9,874 3,146 13,020 Construction in progress 10,071 (6,744) 3,327 Land held for development 46,538 — 46,538 Total real estate investments $ 8,844,747 $ (102,535) $ 8,742,212 Assets held for sale, net 707,442 (7,946) 699,496 Investments in unconsolidated joint ventures 67,892 — 67,892 Cash and cash equivalents 26,034 11,403 37,437 Restricted cash 1,123,647 (1,247) 1,122,400 Operating lease right-of-use assets 198,261 16,370 214,631 Other assets, net (b) (c) 209,163 (3,840) 205,323 Total assets acquired $ 11,177,186 $ (87,795) $ 11,089,391 LIABILITIES Notes and bonds payable $ 3,991,300 $ — $ 3,991,300 Accounts payable and accrued liabilities 1,227,570 17,374 1,244,944 Liabilities of assets held for sale 28,677 (3,939) 24,738 Operating lease liabilities 173,948 10,173 184,121 Financing lease liabilities 10,720 (855) 9,865 Other liabilities 203,210 (8,909) 194,301 Total liabilities assumed $ 5,635,425 $ 13,844 $ 5,649,269 Net identifiable assets acquired $ 5,541,761 $ (101,639) $ 5,440,122 Non-controlling interest $ 110,702 $ — $ 110,702 Goodwill $ 145,404 $ 101,639 $ 247,043 (a) The weighted average amortization period for the acquired lease intangible assets is approximately 6 years. (b) Includes $15.9 million of contractual accounts receivable, which approximates fair value. (c) Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date. The cumulative measurement period adjustments recorded through June 30, 2023 primarily resulted from updated valuations related to the Company’s real estate assets and liabilities and additional information obtained by the Company related to the properties acquired in the Merger and their respective tenants, and resulted in an increase to goodwill of $101.6 million. As of June 30, 2023, the Company had not finalized the determination of fair value of certain tangible and intangible assets acquired and liabilities assumed, including, but not limited to real estate assets and liabilities, notes receivables and goodwill. As such, the assessment of fair value of assets acquired and liabilities assumed is preliminary and was based on information that was available at the time the Condensed Consolidated Financial Statements were prepared. The finalization of the purchase accounting assessment could result in material changes to the Company’s determination of the fair value of assets acquired and liabilities assumed, which will be recorded as measurement period adjustments in the period in which they are identified, up to one year from the Closing Date. A preliminary estimate of approximately $247.0 million has been allocated to goodwill. Goodwill represents the excess of the purchase price over the fair value of the net tangible and intangible assets acquired and liabilities assumed. The recognized goodwill is attributable to expected synergies and benefits arising from the Merger, including anticipated general and administrative cost savings and potential economies of scale benefits in both tenant and vendor relationships following the closing of the Merger. None of the goodwill recognized is expected to be deductible for tax purposes. Merger-related Costs The Company incurred Merger-related costs of $(15.7) million and $(10.8) million, respectively, during the three and six months ended June 30, 2023, which were included within Merger-related costs in results of operations. The Merger-related costs primarily consist of legal, consulting, severance, and banking services and included a refund of $17.8 million for transfer taxes paid during the year ended December 31, 2022. Subsequent Activity As of the date of these financial statements, the purchase price allocation of fair value was finalized with no additional adjustments. The Company determined the final fair value of net assets acquired based on information available during the measurement period.

Real Estate Investments

Real Estate Investments	6 Months Ended
	Jun. 30, 2023
Business Combination and Asset Acquisition [Abstract]
Real Estate Investments	Real Estate Investments 2023 Acquisition Activity The following table details the Company's real estate acquisition activity for the six months ended June 30, 2023: Dollars in thousands DATE ACQUIRED PURCHASE PRICE CASH 1 REAL OTHER 2 SQUARE FOOTAGE Tampa, FL 3/10/23 $ 31,500 $ 30,499 $ 30,596 $ (97) 115,867 1 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 2 Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. In the second quarter of 2023, the Company entered into a joint venture agreement for the development of a medical office building in Scottsdale, Arizona. The Company holds a 90% interest in the joint venture and determined the arrangement meets the criteria to be consolidated. The joint venture acquired an $8.8 million land parcel to be developed with the Company contributing cash of $8.3 million. Subsequent to June 30, 2023, the Company acquired the following property: Dollars in thousands DATE ACQUIRED PURCHASE PRICE SQUARE FOOTAGE Colorado Springs, CO 7/28/23 $ 11,450 42,770 Unconsolidated Joint Ventures The Company's investment in and loss recognized for the three and six months ended June 30, 2023 and 2022 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below: THREE MONTHS ENDED SIX MONTHS ENDED Dollars in thousands 2023 2022 2023 2022 Investments in unconsolidated joint ventures, beginning of period $ 327,746 $ 211,195 $ 327,248 $ 161,942 New investment during the period 1 — — 3,824 49,599 Equity loss recognized during the period (17) (307) (797) (652) Owner distributions (484) (107) (3,030) (108) Investments in unconsolidated joint ventures, end of period $ 327,245 $ 210,781 $ 327,245 $ 210,781 1 In 2023, this was an additional investment in an existing joint venture in which the Company owns a 40% ownership interest. The investment consisted of a sale of a property in Dallas, Texas to the joint venture. See 2023 Real Estate Asset Dispositions below for additional information. 2023 Real Estate Asset Dispositions The following table details the Company's dispositions for the six months ended June 30, 2023: Dollars in thousands DATE DISPOSED SALE PRICE CLOSING ADJUSTMENTS COMPANY-FINANCED MORTGAGE NOTES NET PROCEEDS NET REAL ESTATE INVESTMENT OTHER (INCLUDING RECEIVABLES) 1 GAIN/(IMPAIRMENT) SQUARE FOOTAGE Tampa, FL & Miami, FL 2 1/12/23 $ 93,250 $ (5,875) $ — $ 87,375 $ 87,302 $ (888) $ 961 224,037 Dallas, TX 3 1/30/23 19,210 (141) — 19,069 18,986 43 40 36,691 St. Louis, MO 2/10/23 350 (18) — 332 398 — (66) 6,500 Los Angeles, CA 3/23/23 21,000 (526) — 20,474 20,610 52 (188) 37,165 Los Angeles, CA 4 3/30/23 75,000 (8,079) (45,000) 21,921 88,624 (803) (20,900) 147,078 Los Angeles, CA 5 5/12/23 3,300 (334) — 2,966 3,268 — (302) — Albany, NY 6/30/23 10,000 (1,229) — 8,771 2,613 (1,040) 7,198 40,870 Total dispositions $ 222,110 $ (16,202) $ (45,000) $ 160,908 $ 221,801 $ (2,636) $ (13,257) 492,341 1 Includes straight-line rent receivables, leasing commissions and lease inducements. 2 Includes two properties, sold in two separate transactions to the same buyer on the same date. 3 The Company sold this property to a joint venture in which it retained a 40% interest. Sales price and square footage reflect the total sales price paid by the joint venture and total square footage of the property. 4 The Company entered into a mortgage note agreement with the buyer for $45 million. 5 The Company sold a land parcel totaling 0.34 acres. Subsequent to June 30, 2023, the Company disposed of the following property: Dollars in thousands DATE DISPOSED SALES PRICE SQUARE FOOTAGE Houston, TX 8/2/23 $ 8,320 57,170 Assets Held for Sale The Company had three properties classified as assets held for sale as of June 30, 2023. The net real estate assets held for sale includes $3.6 million of impairment charges for the six months ended June 30, 2023. The Company had one property classified as assets held for sale as of December 31, 2022, which was sold in the first quarter of 2023. The table below reflects the assets and liabilities classified as held for sale as of June 30, 2023 and December 31, 2022: Dollars in thousands June 30, 2023 December 31, 2022 Balance Sheet data: Land $ 205 $ 1,700 Building and improvements 1,736 15,164 Lease intangibles 2,242 1,986 4,183 18,850 Accumulated depreciation (4,183) — Real estate assets held for sale, net — 18,850 Other assets, net 151 43 Assets held for sale, net $ 151 $ 18,893 Accounts payable and accrued liabilities $ 222 $ 282 Other liabilities — 155 Liabilities of assets held for sale $ 222 $ 437

Leases

Leases	6 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Leases	Leases Lessor Accounting The Company’s properties generally were leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide tenants with fixed rent renewal terms while others have market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company’s single-tenant net leases generally require the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property. The Company's leases typically have escalators that are either based on a stated percentage or an index such as the consumer price index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three and six months ended June 30, 2023 was $329.7 million and $653.8 million, respectively. Lease income for the Company's operating leases recognized for the three and six months ended June 30, 2022 was $140.6 million and $279.1 million, respectively. Future lease payments under the non-cancelable operating leases, excluding any reimbursements and the sale-type lease, as of June 30, 2023 were as follows: Dollars in thousands OPERATING 2023 $ 467,393 2024 861,323 2025 751,369 2026 648,352 2027 536,874 2028 and thereafter 1,950,019 $ 5,215,330 Lessee Accounting As of June 30, 2023, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company’s ground leases. As of June 30, 2023, the Company had 241 properties totaling 17.5 million square feet that were held under ground leases. Some of the ground lease renewal terms are based on fixed rent renewal terms and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company’s ground leases are generally either stated or based on CPI. The Company had 75 prepaid ground leases as of June 30, 2023. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $0.3 million and $0.1 million of the Company’s rental expense for the three months ended June 30, 2023 and 2022, respectively, and $0.7 million and $0.3 million for the six months ended June 30, 2023 and 2022, respectively. The Company’s future lease payments (primarily for its 166 non-prepaid ground leases) as of June 30, 2023 were as follows: Dollars in thousands OPERATING FINANCING 2023 $ 7,315 $ 992 2024 15,011 2,182 2025 14,597 2,218 2026 14,631 2,255 2027 14,701 2,294 2028 and thereafter 929,853 396,398 Total undiscounted lease payments 996,108 406,339 Discount (717,629) (332,710) Lease liabilities $ 278,479 $ 73,629 The following table provides details of the Company's total lease expense for the three and six months ended June 30, 2023 and 2022: THREE MONTHS ENDED SIX MONTHS ENDED Dollars in thousands 2023 2022 2023 2022 Operating lease cost Operating lease expense $ 5,329 $ 1,194 $ 10,436 $ 2,409 Variable lease expense 2,235 1,038 4,371 2,062 Finance lease cost Amortization of right-of-use assets 387 331 774 503 Interest on lease liabilities 923 765 1,841 1,052 Total lease expense $ 8,874 $ 3,328 $ 17,422 $ 6,026 Other information Operating cash flows outflows related to operating leases $ 5,230 $ 1,799 $ 11,190 $ 4,596 Operating cash flows outflows related to financing leases $ 541 $ 509 $ 1,094 $ 767 Financing cash flows outflows related to financing leases $ 6 $ — $ 17 $ 51 Right-of-use assets obtained in exchange for new finance lease liabilities $ — $ — $ — $ 40,589 Weighted-average years remaining lease term (excluding renewal options) - operating leases 47.3 47.4 Weighted-average years remaining lease term (excluding renewal options) - finance leases 58.4 61.7 Weighted-average discount rate - operating leases 5.8 % 5.6 % Weighted-average discount rate - finance leases 5.0 % 5.0 %
Leases	Leases Lessor Accounting The Company’s properties generally were leased pursuant to non-cancelable, fixed-term operating leases with expiration dates through 2052. Some leases provide tenants with fixed rent renewal terms while others have market rent renewal terms. Some leases provide the lessee, during the term of the lease, with an option or right of first refusal to purchase the leased property. The Company’s single-tenant net leases generally require the lessee to pay minimum rent and all taxes (including property tax), insurance, maintenance and other operating costs associated with the leased property. The Company's leases typically have escalators that are either based on a stated percentage or an index such as the consumer price index ("CPI"). In addition, most of the Company's leases include nonlease components, such as reimbursement of operating expenses as additional rent, or include the reimbursement of expected operating expenses as part of the lease payment. The Company adopted an accounting policy to combine lease and nonlease components. Rent escalators based on indices and reimbursements of operating expenses that are not included in the lease rate are considered variable lease payments. Variable payments are recognized in the period earned. Lease income for the Company's operating leases recognized for the three and six months ended June 30, 2023 was $329.7 million and $653.8 million, respectively. Lease income for the Company's operating leases recognized for the three and six months ended June 30, 2022 was $140.6 million and $279.1 million, respectively. Future lease payments under the non-cancelable operating leases, excluding any reimbursements and the sale-type lease, as of June 30, 2023 were as follows: Dollars in thousands OPERATING 2023 $ 467,393 2024 861,323 2025 751,369 2026 648,352 2027 536,874 2028 and thereafter 1,950,019 $ 5,215,330 Lessee Accounting As of June 30, 2023, the Company was obligated, as the lessee, under operating lease agreements consisting primarily of the Company’s ground leases. As of June 30, 2023, the Company had 241 properties totaling 17.5 million square feet that were held under ground leases. Some of the ground lease renewal terms are based on fixed rent renewal terms and others have market rent renewal terms. These ground leases typically have initial terms of 40 to 99 years with expiration dates through 2119. Any rental increases related to the Company’s ground leases are generally either stated or based on CPI. The Company had 75 prepaid ground leases as of June 30, 2023. The amortization of the prepaid rent, included in the operating lease right-of-use asset, represented approximately $0.3 million and $0.1 million of the Company’s rental expense for the three months ended June 30, 2023 and 2022, respectively, and $0.7 million and $0.3 million for the six months ended June 30, 2023 and 2022, respectively. The Company’s future lease payments (primarily for its 166 non-prepaid ground leases) as of June 30, 2023 were as follows: Dollars in thousands OPERATING FINANCING 2023 $ 7,315 $ 992 2024 15,011 2,182 2025 14,597 2,218 2026 14,631 2,255 2027 14,701 2,294 2028 and thereafter 929,853 396,398 Total undiscounted lease payments 996,108 406,339 Discount (717,629) (332,710) Lease liabilities $ 278,479 $ 73,629 The following table provides details of the Company's total lease expense for the three and six months ended June 30, 2023 and 2022: THREE MONTHS ENDED SIX MONTHS ENDED Dollars in thousands 2023 2022 2023 2022 Operating lease cost Operating lease expense $ 5,329 $ 1,194 $ 10,436 $ 2,409 Variable lease expense 2,235 1,038 4,371 2,062 Finance lease cost Amortization of right-of-use assets 387 331 774 503 Interest on lease liabilities 923 765 1,841 1,052 Total lease expense $ 8,874 $ 3,328 $ 17,422 $ 6,026 Other information Operating cash flows outflows related to operating leases $ 5,230 $ 1,799 $ 11,190 $ 4,596 Operating cash flows outflows related to financing leases $ 541 $ 509 $ 1,094 $ 767 Financing cash flows outflows related to financing leases $ 6 $ — $ 17 $ 51 Right-of-use assets obtained in exchange for new finance lease liabilities $ — $ — $ — $ 40,589 Weighted-average years remaining lease term (excluding renewal options) - operating leases 47.3 47.4 Weighted-average years remaining lease term (excluding renewal options) - finance leases 58.4 61.7 Weighted-average discount rate - operating leases 5.8 % 5.6 % Weighted-average discount rate - finance leases 5.0 % 5.0 %

Notes and Bonds Payable

Notes and Bonds Payable	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Notes and Bonds Payable	Notes and Bonds Payable The table below details the Company’s notes and bonds payable as of June 30, 2023 and December 31, 2022. MATURITY DATES BALANCE 1 AS OF EFFECTIVE INTEREST RATE Dollars in thousands 6/30/2023 12/31/2022 $1.5 billion Unsecured Credit Facility 10/25 $ 354,000 $ 385,000 6.05 % $350 million Unsecured Term Loan 2 7/24 349,499 349,114 6.21 % $200 million Unsecured Term Loan 5/24 199,786 199,670 6.21 % $300 million Unsecured Term Loan 10/25 299,947 299,936 6.21 % $150 million Unsecured Term Loan 6/26 149,569 149,495 6.21 % $200 million Unsecured Term Loan 7/27 199,432 199,362 6.21 % $300 million Unsecured Term Loan 1/28 298,079 297,869 6.21 % Senior Notes due 2025 5/25 249,298 249,115 4.12 % Senior Notes due 2026 8/26 575,256 571,587 4.94 % Senior Notes due 2027 7/27 481,615 479,553 4.76 % Senior Notes due 2028 1/28 297,138 296,852 3.85 % Senior Notes due 2030 2/30 570,356 565,402 5.30 % Senior Notes due 2030 3/30 296,579 296,385 2.72 % Senior Notes due 2031 3/31 295,795 295,547 2.25 % Senior Notes due 2031 3/31 640,999 632,693 5.13 % Mortgage notes payable 8/23-12/26 82,924 84,247 3.57%-4.84% $ 5,340,272 $ 5,351,827 . 1 Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable. 2 On April 26, 2023, the Company exercised its option to extend the maturity date for one year for a fee of approximately $0.4 million. Subsequent Changes in Debt Structure

Derivative Financial Instrument

Derivative Financial Instruments	6 Months Ended
	Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Financial Instruments	Derivative Financial Instruments Risk Management Objective of Using Derivatives The Company is exposed to certain risks arising from both its business operations and economic conditions. The Company principally manages its exposures to a wide variety of business and operational risks through management of its core business activities. The Company manages economic risks, including interest rate, liquidity, and credit risk, primarily by managing the amount, sources, and duration of its assets and liabilities and the use of derivative financial instruments. Specifically, the Company enters into derivative financial instruments to manage exposures that arise from business activities that result in the receipt or payment of future known and uncertain cash amounts, the value of which are determined by interest rates. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to the Company’s borrowings. Cash Flow Hedges of Interest Rate Risk The Company’s objectives in using interest rate derivatives are to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company primarily uses interest rate swaps as part of its interest rate risk management strategy. Interest rate swaps designated as cash flow hedges involve the receipt of variable amounts from a counterparty in exchange for the Company making fixed-rate payments over the life of the agreements without exchange of the underlying notional amount. Such derivatives were used to hedge the variable cash flows associated with existing variable-rate debt. For derivatives designated, and that qualify, as cash flow hedges of interest rate risk, the gain or loss on the derivative is recorded in Accumulated Other Comprehensive Income (Loss) ("AOCI") and subsequently reclassified into interest expense in the same period(s) during which the hedged transaction affects earnings. Amounts reported in AOCI related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable-rate debt. As of June 30, 2023, the Company had 14 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk: EXPIRATION DATE AMOUNT WEIGHTED January 15, 2024 $ 200,000 1.21 % May 1, 2026 100,000 2.15 % June 1, 2026 150,000 3.83 % December 1, 2026 150,000 3.84 % June 1, 2027 150,000 4.13 % December 1, 2027 250,000 3.79 % $ 1,000,000 3.17 % Tabular Disclosure of Fair Values of Derivative Instruments on the Balance Sheet The table below presents the fair value of the Company's derivative financial instruments, as well as their classification on the Condensed Consolidated Balance Sheet as of June 30, 2023. BALANCE AT JUNE 30, 2023 In thousands BALANCE SHEET LOCATION FAIR VALUE Derivatives designated as hedging instruments Interest rate swaps Other liabilities $ (1,248) Interest rate swaps Other assets $ 16,046 Total derivatives designated as hedging instruments $ 14,798 Tabular Disclosure of the Effect of Cash Flow Hedge Accounting on Accumulated Other Comprehensive Income (Loss) The table below presents the effect of cash flow hedge accounting on AOCI during the three and six months ended June 30, 2023 and 2022 related to the Company's outstanding interest rate swaps. (GAIN)/LOSS RECOGNIZED IN (GAIN)/LOSS RECLASSIFIED FROM In thousands 2023 2022 2023 2022 Interest rate swaps $ (21,523) $ (1,663) Interest expense $ (3,568) $ 674 Settled treasury hedges — — Interest expense 107 107 Settled interest rate swaps — — Interest expense 42 42 $ (21,523) $ (1,663) Total interest expense $ (3,419) $ 823 (GAIN)/LOSS RECOGNIZED IN (GAIN)/LOSS RECLASSIFIED FROM In thousands 2023 2022 2023 2022 Interest rate swaps $ (12,981) $ (6,822) Interest expense $ (6,000) $ 1,612 Settled treasury hedges — — Interest expense 213 213 Settled interest rate swaps — — Interest expense 84 84 $ (12,981) $ (6,822) Total interest expense $ (5,703) $ 1,909 The Company estimates that an additional $14.4 million related to active interest rate swaps will be reclassified from AOCI as a decrease to interest expense over the next 12 months, and that an additional $0.6 million related to settled interest rate swaps will be amortized from AOCI as an increase to interest expense over the next 12 months. Credit-risk-related Contingent Features The Company's agreements with each of its derivative counterparties contain a cross-default provision under which the Company could be declared in default of its derivative obligations if repayment of the underlying indebtedness is accelerated by the lender due to the Company's default on the indebtedness. As of June 30, 2023, the fair value of derivatives in a net asset position including accrued interest but excluding any adjustment for nonperformance risk related to these agreements was $15.4 million. As of June 30, 2023, the Company had not posted any collateral related to these agreements and was not in breach of any agreement.

Commitments and Contingencies

Commitments and Contingencies	6 Months Ended
	Jun. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and Contingencies Legal Proceedings The Company is, from time to time, involved in litigation arising in the ordinary course of business. The Company is not aware of any pending or threatened litigation that, if resolved against the Company, would have a material adverse effect on the Company’s consolidated financial position, results of operations or cash flows. Development and Redevelopment Activity During the first six months of 2023, the Company incurred $49.0 million toward the development and redevelopment of properties.

Stockholders' Equity

Stockholders' Equity	6 Months Ended
	Jun. 30, 2023
Equity [Abstract]
Stockholders' Equity	Stockholders' Equity Common Stock The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the six months ended June 30, 2023 and the twelve months ended December 31, 2022: SIX MONTHS ENDED JUNE 30, 2023 TWELVE MONTHS ENDED DECEMBER 31, 2022 Balance, beginning of period 380,589,894 150,457,433 Issuance of common stock 4,817 229,618,304 Non-vested share-based awards, net of withheld shares 262,821 514,157 Balance, end of period 380,857,532 380,589,894 At-The-Market Equity Offering Program The Company has equity distribution agreements with various sales agents with respect to the at-the-market (“ATM”) offering program of common stock with an aggregate sales amount of up to $750.0 million. As of June 30, 2023, $750.0 million remained available for issuance under our current ATM offering program. During the six months ended June 30, 2023, the Company did not sell any shares or enter into any forward sale agreements to sell shares of common stock through its ATM offering program. Common Stock Dividends During the six months ended June 30, 2023, the Company declared and paid common stock dividends totaling $0.62 per share. On August 1, 2023, the Company declared a quarterly common stock dividend in the amount of $0.31 per share payable on August 30, 2023 to stockholders of record on August 15, 2023. Earnings Per Common Share The Company uses the two-class method of computing net earnings per common shares. The Company's non-vested share-based awards are considered participating securities pursuant to the two-class method. The following table sets forth the computation of basic and diluted earnings per common share for the three and six months ended June 30, 2023 and 2022. THREE MONTHS ENDED JUNE 30, SIX MONTHS ENDED JUNE 30, Dollars in thousands, except per share data 2023 2022 2023 2022 Weighted average common shares outstanding Weighted average common shares outstanding 380,829,011 151,620,897 380,812,981 151,230,064 Non-vested shares (1,932,334) (1,945,042) (1,952,350) (1,908,652) Weighted average common shares outstanding - basic 378,896,677 149,675,855 378,860,631 149,321,412 Weighted average common shares outstanding - basic 378,896,677 149,675,855 378,860,631 149,321,412 Dilutive effect of employee stock purchase plan — 62,694 — 75,394 Weighted average common shares outstanding - diluted 378,896,677 149,738,549 378,860,631 149,396,806 Net (loss) income attributable to common stockholders $ (82,759) $ 6,130 $ (169,884) $ 48,357 Dividends paid on nonvested share-based awards (588) (601) (1,193) (1,207) Net (loss) income applicable to common stockholders - basic $ (83,347) $ 5,529 $ (171,077) $ 47,150 Basic earnings per common share - net income $ (0.22) $ 0.04 $ (0.45) $ 0.32 Diluted earnings per common share - net income $ (0.22) $ 0.04 $ (0.45) $ 0.32 The effect of OP units totaling 4,042,993 shares, non-vested stock awards totaling 442,263 shares, and options under the Company's Employee Stock Purchase Plan (the "ESPP") to purchase the Company's common stock totaling 27,484 shares for the three months ended June 30, 2023 were excluded from the calculation of diluted loss per common share because the effect was anti-dilutive due to the loss from continuing operations incurred during that period. Incentive Plans Equity Awards During the six months ended June 30, 2023, the Company made the following equity awards: • During the first quarter of 2023, the Company granted non-vested stock awards to its named executive officers and other members of senior management and employees with a grant date fair value of $5.4 million, which consisted of an aggregate of 270,494 non-vested shares with vesting periods ranging from three • During the second quarter of 2023, the Company granted to its 12 independent directors an aggregate of 42,768 shares of non-vested stock awards with a grant date fair value of $0.7 million, and an aggregate of 57,868 LTIP Series D units with a grant date fair value of $1.1 million. The Company also granted a non-vested stock award to a new employee, which consisted of 508 non-vested shares. A summary of the activity under the Company's share-based incentive plans for the three and six months ended June 30, 2023 and 2022 is included in the table below. THREE MONTHS ENDED JUNE 30, SIX MONTHS ENDED JUNE 30, 2023 2022 2023 2022 Share-based awards, beginning of period 1,955,445 1,951,551 1,795,128 1,562,028 Granted 43,276 26,840 325,816 442,024 Vested (62,640) (36,682) (164,360) (61,047) Forfeited (3,860) — (24,363) (1,296) Share-based awards, end of period 1,932,221 1,941,709 1,932,221 1,941,709 During the six months ended June 30, 2023 and 2022, the Company withheld 38,632 and 6,727 shares of common stock, respectively, from participants to pay estimated withholding taxes related to shares that vested. Restricted Stock Units Prior to 2022, the Company granted long-term incentive awards, comprised of restricted stock, based on backward-looking performance measured at the end of the calendar year. The Company adopted a new incentive compensation structure effective January 2022, comprised of restricted stock and restricted stock units ("RSUs"). The RSUs are granted at the beginning of the year with three-year forward-looking performance targets. On January 4, 2023, the Company granted RSUs to members of senior management, with a grant date fair value of $3.7 million, which consisted of an aggregate 165,174 RSUs with a five-year vesting period. Approximately 43% of the RSUs vest based on two market performance conditions. Relative and absolute total shareholder return ("TSR") awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $24.23 for the absolute TSR component and $27.84 for the relative TSR component for the January 2023 grant using the following assumptions: THREE MONTHS ENDED MARCH 31, Volatility 34.0 % Dividend assumption Accrued Expected term 3 years Risk-free rate 4.42 % Stock price (per share) $20.21 The remaining 57% of the RSUs vest based upon certain operating performance conditions. With respect to the operating performance conditions of the January 4, 2023 grant, the grant date fair value was $20.21 based on the Company's share price on the date of grant. The combined weighted average grant date fair value of the January RSUs was $22.55 per share. The following is a summary of the RSU activity during the three and six months ended June 30, 2023: THREE MONTHS ENDED JUNE 30, SIX MONTHS ENDED JUNE 30, Restricted Stock Units Weighted Average Grant Date Fair Value Restricted Stock Units Weighted Average Grant Date Fair Value Non-vested, beginning of period 363,250 $ 28.57 294,932 33.04 Granted — — 165,174 $ 22.55 Vested/Forfeited — — (17,606) 33.04 Probability adjustment of 2022 RSUs — — (79,250) 31.68 Non-vested, end of period 363,250 $ 28.57 363,250 28.57 LTIP Series C Units In January 2023, the Company modified its incentive compensation structure to award LTIP Series C units ("LTIP-C units) in the OP to named executive officers in lieu of RSUs. The LTIP-C units are granted with three-year forward-looking performance targets, with a grant date fair value of $7.1 million, which consisted of an aggregate 448,249 LTIP-C units with a five-year vesting period. Approximately 43% of the LTIP-C units vest based on two market performance conditions. Relative and absolute TSR awards containing these market performance conditions were valued using independent specialists. The Company utilized a Monte Carlo simulation to calculate the weighted average grant date fair values of $12.24 for the absolute TSR component and $13.98 for the relative TSR component for the January 2023 grant using the following assumption: THREE MONTHS ENDED MARCH 31, Volatility 34.0 % Dividend assumption Accrued Expected term 3 years Risk-free rate 4.42 % Stock price (per share) $20.21 The remaining 57% of the LTIP-C units vest based upon certain operating performance conditions. With respect to the operating performance conditions of the January 4, 2023 grant, the grant date fair value was $20.21 based on the Company's share price on the date of grant. The combined weighted average grant date fair value of the January LTIP-C units was $15.85 per share. Employee Stock Purchase Plan Legacy HR maintained an ESPP prior to the completion of the Merger. The outstanding options to purchase shares of the common stock of Legacy HR became options to purchase class A common stock of the Company upon completion of the Merger. No new options will be granted under the ESPP. A summary of the activity under the ESPP for the three and six months ended June 30, 2023 and 2022 is included in the table below. THREE MONTHS ENDED JUNE 30, SIX MONTHS ENDED JUNE 30, 2023 2022 2023 2022 Outstanding and exercisable, beginning of period 183,426 427,802 340,976 348,514 Granted — — — 255,960 Exercised (1,687) (1,965) (4,817) (12,518) Forfeited (2,370) (20,303) (23,791) (45,789) Expired — — (132,999) (140,633) Outstanding and exercisable, end of period 179,369 405,534 179,369 405,534 The following table represents expected amortization of the Company's non-vested shares issued as of June 30, 2023: Dollars in millions FUTURE AMORTIZATION 2023 $ 7.7 2024 13.3 2025 10.8 2026 8.0 2027 2.4 2028 and thereafter 0.5 Total $ 42.7

Fair Value of Financial Instrum

Fair Value of Financial Instruments	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments The following methods and assumptions were used to estimate the fair value of each class of financial instrument for which it is practical to estimate that value. • Cash and cash equivalents - The carrying amount approximates fair value due to the short term maturity of these investments. • Real estate notes receivabl e - Real estate notes receivable are recorded in other assets on the Company's Condensed Consolidated Balance Sheets. Fair value is estimated using cash flow analyses, based on current interest rates for similar types of arrangements. • Borrowings under the Unsecured Credit Facility and the Term Loans Due 2024 and 2026 - The carrying amount approximates fair value because the borrowings are based on variable market interest rates. • Senior Notes and Mortgage Notes payable - The fair value of notes and bonds payable is estimated using cash flow analyses, based on the Company’s current interest rates for similar types of borrowing arrangements. • Interest rate swap agreements - Interest rate swap agreements are recorded in other liabilities on the Company's Condensed Consolidated Balance Sheets at fair value. Fair value is estimated by utilizing pricing models, level 2 inputs, that consider forward yield curves and discount rates. The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at June 30, 2023 and December 31, 2022. June 30, 2023 December 31, 2022 Dollars in millions CARRYING VALUE FAIR VALUE CARRYING VALUE FAIR VALUE Notes and bonds payable 1 $ 5,340.3 $ 5,107.5 $ 5,351.8 $ 5,149.6 Real estate notes receivable 1 $ 151.5 $ 149.0 $ 99.6 $ 99.6 1 Level 2 – model-derived valuations in which significant inputs and significant value drivers are observable in active markets.

Pay vs Performance Disclosure

Pay vs Performance Disclosure - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Pay vs Performance Disclosure
Net income (loss)	$ (82,759)	$ 6,130	$ (169,884)	$ 48,357

Insider Trading Arrangements

Insider Trading Arrangements	3 Months Ended
	Jun. 30, 2023
Trading Arrangements, by Individual
Rule 10b5-1 Arrangement Adopted	false
Non-Rule 10b5-1 Arrangement Adopted	false
Rule 10b5-1 Arrangement Terminated	false
Non-Rule 10b5-1 Arrangement Terminated	false

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Business Overview	Business Overview Healthcare Realty Trust Incorporated is a real estate investment trust ("REIT") that owns, leases, manages, acquires, finances, develops and redevelops income-producing real estate properties associated primarily with the delivery of outpatient healthcare services throughout the United States. As of June 30, 2023, the Company had gross investments of approximately $13.9 billion in 680 wholly-owned real estate properties, construction in progress, redevelopments, financing receivables, financing lease right-of-use assets, land held for development and corporate property. The Company's 680 real estate properties are located in 35 states and total approximately 39.8 million square feet. The Company provided leasing and property management services to approximately 39.3 million square feet nationwide. In addition, as of June 30, 2023, the Company had a weighted average ownership interest of approximately 44% in 34 real estate properties held in joint ventures. See Note 3 below for more details regarding the Company's unconsolidated joint ventures.
Basis of Presentation	Basis of Presentation For purposes of this Quarterly Report on Form 10-Q, references to the “Company” are to Legacy HR for periods prior to the closing of the Merger and thereafter to Legacy HR and Legacy HTA as the combined company after giving effect to the Merger. The Merger is described in more detail in Note 2 to these Condensed Consolidated Financial Statements. The Condensed Consolidated Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. They do not include all of the information and footnotes required by GAAP for complete financial statements. However, except as disclosed herein and specific disclosures included as a result of the Merger, management believes there has been no material change in the information disclosed in the Notes to the Consolidated Financial Statements included in the Company's Annual Report on Form 10-K for the year ended December 31, 2022. All material intercompany transactions and balances have been eliminated in consolidation. This interim financial information should be read in conjunction with the consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2022. Management believes that all adjustments of a normal, recurring nature considered necessary for a fair presentation have been included. In addition, the interim financial information does not necessarily represent or indicate what the operating results will be for the year ending December 31, 2023 for many reasons including, but not limited to, acquisitions, dispositions, capital financing transactions, changes in interest rates and the effects of other trends, risks and uncertainties.
Principles of Consolidation	Principles of Consolidation The Company’s Condensed Consolidated Financial Statements include the accounts of the Company, its wholly owned subsidiaries, and joint ventures and partnerships where the Company controls the operating activities. GAAP requires us to identify entities for which control is achieved through means other than voting rights and to determine which business enterprise is the primary beneficiary of variable interest entities (“VIEs”). Accounting Standards Codification (“ASC”) Topic 810, Consolidation broadly defines a VIE as an entity in which either (i) the equity investors as a group, if any, lack the power through voting or similar rights to direct the activities of such entity that most significantly impact such entity’s economic performance or (ii) the equity investment at risk is insufficient to finance that entity’s activities without additional subordinated financial support. The Company identifies the primary beneficiary of a VIE as the enterprise that has both of the following characteristics: (i) the power to direct the activities of the VIE that most significantly impact the entity’s economic performance and (ii) the obligation to absorb losses or receive benefits of the VIE that could potentially be significant to the entity. The Company consolidates its investment in a VIE when it determines that it is the VIE’s primary beneficiary, with any minority interests reflected as non-controlling interests or redeemable non-controlling interests in the accompanying Condensed Consolidated Financial Statements. The Company may change its original assessment of a VIE upon subsequent events such as the modification of contractual arrangements that affect the characteristics or adequacy of the entity’s equity investments at risk, the disposition of all or a portion of an interest held by the primary beneficiary, or changes in facts and circumstances that impact the power to direct activities of the VIE that most significantly impacts economic performance. The Company performs this analysis on an ongoing basis. For property holding entities not determined to be VIEs, the Company consolidates such entities in which it owns 100% of the equity or has a controlling financial interest evidenced by ownership of a majority voting interest. All intercompany balances and transactions are eliminated in consolidation. For entities in which the Company owns less than 100% of the equity interest, the Company consolidates the entity if it has the direct or indirect ability to control the entities’ activities based upon the terms of the respective entities’ ownership agreements. Healthcare Realty Holdings, L.P., a Delaware limited partnership (the "OP"), is 98.8% owned by the Company. Holders of operating partnership units (“OP Units”) are considered to be non-controlling interest holders in the OP and their ownership interests are reflected as equity on the accompanying Condensed Consolidated Balance Sheets. Further, a portion of the earnings and losses of the OP are allocated to non-controlling interest holders based on their respective ownership percentages. Upon conversion of OP Units to common stock, any difference between the fair value of the common stock issued and the carrying value of the OP Units converted to common stock is recorded as a component of equity. As of June 30, 2023, there were approximately 4.7 million OP Units, or 1.2% of OP units issued and outstanding, held by non-controlling interest holders. Additionally, the Company is the primary beneficiary of this VIE. Accordingly, the Company consolidates the interests in the OP. As of June 30, 2023, the Company had four consolidated VIEs in addition to the OP where it is the primary beneficiary of the VIE based on the combination of operational control and the rights to receive residual returns or the obligation to absorb losses arising from the joint ventures. Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate: (dollars in thousands) JUNE 30, 2023 Assets: Net real estate investments $ 61,980 Cash and cash equivalents 2,107 Receivables and other assets 2,015 Total assets $ 66,102 Liabilities: Accrued expenses and other liabilities $ 14,058 Total equity 52,044 Total liabilities and equity $ 66,102 As of June 30, 2023, the Company had three unconsolidated VIEs consisting of two notes receivables and one joint venture. The Company does not have the power or economic interests to direct the activities of the VIEs on a stand-alone basis, and therefore it was determined that the Company was not the primary beneficiary. As a result, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method. See below for additional information regarding the Company's unconsolidated VIEs. (dollars in thousands) ORIGINATION DATE LOCATION SOURCE CARRYING AMOUNT MAXIMUM EXPOSURE TO LOSS 2021 Houston, TX 1 Note receivable $ 30,445 $ 31,150 2021 Charlotte, NC 1 Note receivable 5,691 6,000 2022 Texas 2 Joint venture 64,758 64,758 1 Assumed mortgage note receivable in connection with the Merger. 2 Includes investments in seven properties.
Variable Interest Entities	As of June 30, 2023, the Company's unconsolidated joint venture arrangements were accounted for using the equity method of accounting as the Company exercised significant influence over but did not control these entities.
Use of Estimates in the Condensed Consolidated Financial Statements	Use of Estimates in the Condensed Consolidated Financial Statements Preparation of the Condensed Consolidated Financial Statements in accordance with GAAP requires management to make estimates and assumptions that affect amounts reported in the Condensed Consolidated Financial Statements and accompanying notes. Actual results may differ from those estimates.
Reclassifications	Reclassifications Certain reclassifications have been made on the Company's prior year Condensed Consolidated Balance Sheet to conform to current year presentation. Previously, the Company's Lease intangibles were included in Building, improvements and lease intangibles and Goodwill was included with Other assets, net. These amounts are now classified as separate line items on the Company's Condensed Consolidated Balance Sheets.
Redeemable Non-Controlling Interests	Redeemable Non-Controlling InterestsThe Company accounts for redeemable equity securities in accordance with ASC Topic 480: Accounting for Redeemable Equity Instruments, which requires that equity securities redeemable at the option of the holder, not solely within our control, be classified outside permanent stockholders’ equity. The Company classifies redeemable equity securities as redeemable non-controlling interests in the accompanying Condensed Consolidated Balance Sheets. Accordingly, the Company records the carrying amount at the greater of the initial carrying amount (increased or decreased for the non-controlling interest’s share of net income or loss and distributions) or the redemption value. We measure the redemption value and record an adjustment to the carrying value of the equity securities as a component of redeemable non-controlling interest.
Asset Impairment	Asset ImpairmentThe Company assesses the potential for impairment of identifiable, definite-lived, intangible assets and long-lived assets, including real estate properties, whenever the occurrence of an event or a change in circumstances indicates that the carrying value might not be fully recoverable. Indicators of impairment may include significant underperformance of an asset relative to historical or expected operating results; significant changes in the Company’s use of assets or the strategy for its overall business; plans to sell an asset before its depreciable life has ended; the expiration of a significant portion of leases in a property; or significant negative economic trends or negative industry trends for the Company or its tenants.
Investments in Leases - Financing Receivables, Net and Real Estate Notes Receivable and Interest Income	Investments in Leases - Financing Receivables, Net In accordance with ASC Topic 842: Leases, for transactions in which the Company enters into a contract to acquire an asset and leases it back to the seller (i.e., a sale leaseback transaction), control of the asset is not considered to have transferred when the seller-lessee has a purchase option. As a result, the Company does not recognize the underlying real estate asset but instead recognizes a financial asset in accordance with ASC Topic 310: Receivables. See below for additional information regarding the Company's financing receivables. (dollars in thousands) ORIGINATION DATE LOCATION INTEREST RATE CARRYING VALUE as of JUNE 30, 2023 May 2021 Poway, CA 5.73% $ 113,967 November 2021 Columbus, OH 6.48% 7,348 $ 121,315 Real Estate Notes Receivable Real estate notes receivable consists of mezzanine and other real estate loans, which are generally collateralized by a pledge of the borrower’s ownership interest in the respective real estate owner, a mortgage or deed of trust, and/or corporate guarantees. Real estate notes receivable are intended to be held-to-maturity and are recorded at amortized cost, net of unamortized loan origination costs and fees and allowance for credit losses. As of June 30, 2023, real estate notes receivable, net, which are included in Other assets on the Company's Condensed Consolidated Balance Sheets, totaled $151.5 million. (dollars in thousands) ORIGINATION MATURITY STATED INTEREST RATE MAXIMUM LOAN COMMITMENT OUTSTANDING as of ALLOWANCE FOR CREDIT LOSSES FAIR VALUE DISCOUNT AND FEES CARRYING VALUE as of JUNE 30, 2023 Mezzanine loans Texas 6/24/2021 6/24/2024 8.00 % $ 54,119 $ 54,119 $ (5,196) $ (3,067) $ 45,856 Mortgage loans Texas 6/30/2021 12/31/2023 7.00 % 31,150 31,150 — (705) 30,445 North Carolina 12/22/2021 12/22/2024 8.00 % 6,000 6,000 — (309) 5,691 Florida 5/17/2022 2/27/2026 6.00 % 65,000 24,556 — (55) 24,501 California 3/30/2023 3/29/2026 6.00 % 45,000 45,000 — — 45,000 147,150 106,706 — (1,069) 105,637 $ 201,269 $ 160,825 $ (5,196) $ (4,136) $ 151,493 Allowance for Credit Losses Pursuant to ASC Topic 326, Financial Instruments - Credit Losses, the Company adopted a policy to evaluate current expected credit losses at the inception of loans qualifying for treatment under ASC Topic 326. The Company utilizes a probability of default method approach for estimating current expected credit losses and evaluates the liquidity and creditworthiness of its borrowers on a quarterly basis to determine whether any updates to the future expected losses recognized upon inception are necessary. The Company’s evaluation considers industry and economic conditions, credit enhancements, liquidity, and other factors. In its assessment of current expected credit losses for real estate notes receivable, the Company utilizes past payment history of its borrowers, current economic conditions, and forecasted economic conditions through the maturity date of each note to estimate a probability of default and a resulting loss for each real estate note receivable. During the six months ended June 30, 2023, the Company determined that the risk of credit loss on its mezzanine loans was no longer remote. Consequently, the Company recorded a credit loss reserve of $5.2 million for the six months ended June 30, 2023. The following table summarizes the Company's allowance for credit losses on real estate notes receivable: Dollars in thousands June 30, 2023 December 31, 2022 Allowance for credit losses, beginning of period $ — $ — Credit loss reserves 5,196 — Allowance for credit losses, end of period $ 5,196 $ — Interest Income Income from Lease Financing Receivables The Company recognized the related income from two financing receivables totaling $2.1 million and $4.2 million, respectively, for the three and six months ended June 30, 2023, and $2.0 million and $3.9 million, respectively for the three and six months ended June 30, 2022, based on an imputed interest rate over the terms of the applicable lease. As a result, the interest recognized from the financing receivable in any particular period will not equal the cash payments from the lease agreement in that period. Acquisition costs incurred in connection with entering into the financing receivable are treated as loan origination fees. These costs are classified with the financing receivable and are included in the balance of the net investment. Amortization of these amounts will be recognized as a reduction to Income from financing receivable, net over the life of the lease. Income from Real Estate Notes Receivable
Revenue from Contracts with Customers (ASC Topic 606)	Revenue from Contracts with Customers (ASC Topic 606) The Company recognizes certain revenue under the core principle of Topic 606. This topic requires an entity to recognize revenue to depict the transfer of promised goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. Lease revenue is not within the scope of Topic 606. To achieve the core principle, the Company applies the five step model specified in the guidance.

Summary of Significant Accoun_3

Summary of Significant Accounting Policies (Tables)	6 Months Ended
	Jun. 30, 2023
Accounting Policies [Abstract]
Schedule of Condensed Balance Sheet	Accordingly, such joint ventures have been consolidated, and the table below summarizes the balance sheets of consolidated VIEs, excluding the OP, in the aggregate: (dollars in thousands) JUNE 30, 2023 Assets: Net real estate investments $ 61,980 Cash and cash equivalents 2,107 Receivables and other assets 2,015 Total assets $ 66,102 Liabilities: Accrued expenses and other liabilities $ 14,058 Total equity 52,044 Total liabilities and equity $ 66,102
Schedule of Variable Interest Entities	As a result, the Company accounts for the two notes receivables as amortized cost and a joint venture arrangement under the equity method. See below for additional information regarding the Company's unconsolidated VIEs. (dollars in thousands) ORIGINATION DATE LOCATION SOURCE CARRYING AMOUNT MAXIMUM EXPOSURE TO LOSS 2021 Houston, TX 1 Note receivable $ 30,445 $ 31,150 2021 Charlotte, NC 1 Note receivable 5,691 6,000 2022 Texas 2 Joint venture 64,758 64,758 1 Assumed mortgage note receivable in connection with the Merger. 2 Includes investments in seven properties.
Schedule of Accounts, Notes, Loans and Financing Receivable	See below for additional information regarding the Company's financing receivables. (dollars in thousands) ORIGINATION DATE LOCATION INTEREST RATE CARRYING VALUE as of JUNE 30, 2023 May 2021 Poway, CA 5.73% $ 113,967 November 2021 Columbus, OH 6.48% 7,348 $ 121,315 (dollars in thousands) ORIGINATION MATURITY STATED INTEREST RATE MAXIMUM LOAN COMMITMENT OUTSTANDING as of ALLOWANCE FOR CREDIT LOSSES FAIR VALUE DISCOUNT AND FEES CARRYING VALUE as of JUNE 30, 2023 Mezzanine loans Texas 6/24/2021 6/24/2024 8.00 % $ 54,119 $ 54,119 $ (5,196) $ (3,067) $ 45,856 Mortgage loans Texas 6/30/2021 12/31/2023 7.00 % 31,150 31,150 — (705) 30,445 North Carolina 12/22/2021 12/22/2024 8.00 % 6,000 6,000 — (309) 5,691 Florida 5/17/2022 2/27/2026 6.00 % 65,000 24,556 — (55) 24,501 California 3/30/2023 3/29/2026 6.00 % 45,000 45,000 — — 45,000 147,150 106,706 — (1,069) 105,637 $ 201,269 $ 160,825 $ (5,196) $ (4,136) $ 151,493
Schedule of Company's Allowance For Credit Losses	The following table summarizes the Company's allowance for credit losses on real estate notes receivable: Dollars in thousands June 30, 2023 December 31, 2022 Allowance for credit losses, beginning of period $ — $ — Credit loss reserves 5,196 — Allowance for credit losses, end of period $ 5,196 $ —
Schedule of Disaggregation of revenue	Below is a detail of the amounts by category: THREE MONTHS ENDED SIX MONTHS ENDED in thousands 2023 2022 2023 2022 Type of Revenue Parking income $ 2,370 $ 1,919 $ 4,761 $ 3,672 Management fee income 1 1,597 783 3,570 1,438 Miscellaneous 263 36 516 103 $ 4,230 $ 2,738 $ 8,847 $ 5,213

Merger with HTA (Tables)

Merger with HTA (Tables)	6 Months Ended
	Jun. 30, 2023
Business Combination and Asset Acquisition [Abstract]
Schedule of Consideration Transferred	The implied consideration transferred on the Closing Date is as follows: Dollars in thousands, except for per share data Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (a) 228,520,990 Exchange ratio 1.00 Implied shares of Legacy HR Common Stock issued 228,520,990 Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (b) $ 24.37 Value of implied Legacy HR Common Stock issued $ 5,569,057 Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services (c) 7,406 Consideration transferred $ 5,576,463 (a) The number of shares of Legacy HTA Common Stock presented above was based on 228,857,717 total shares of Legacy HTA Common Stock outstanding as of the Closing Date, less 192 Legacy HTA fractional shares that were cancelled in lieu of cash and less 336,535 shares of Legacy HTA restricted stock (net of 215,764 shares of Legacy HTA restricted stock withheld). For accounting purposes, these shares were converted to Legacy HR Common Stock, at an exchange ratio of 1.00 share of Legacy HR Common Stock per share of Legacy HTA Common Stock. (b) For accounting purposes, the fair value of Legacy HR Common Stock issued to former holders of Legacy HTA Common Stock was based on the per share closing price of Legacy HR Common Stock on July 20, 2022.
Schedule of Fair Values of the Assets Acquired And Liabilities Assumed	The following table summarizes the preliminary estimated fair values of the assets acquired and liabilities assumed at the Closing Date: Dollars in thousands PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE CUMULATIVE MEASUREMENT PERIOD ADJUSTMENTS PRELIMINARY AMOUNTS RECOGNIZED ON THE CLOSING DATE ASSETS Real estate investments Land $ 985,926 $ 18,359 $ 1,004,285 Buildings and improvements 6,960,418 (119,135) 6,841,283 Lease intangible assets (a) 831,920 1,839 833,759 Financing lease right-of-use assets 9,874 3,146 13,020 Construction in progress 10,071 (6,744) 3,327 Land held for development 46,538 — 46,538 Total real estate investments $ 8,844,747 $ (102,535) $ 8,742,212 Assets held for sale, net 707,442 (7,946) 699,496 Investments in unconsolidated joint ventures 67,892 — 67,892 Cash and cash equivalents 26,034 11,403 37,437 Restricted cash 1,123,647 (1,247) 1,122,400 Operating lease right-of-use assets 198,261 16,370 214,631 Other assets, net (b) (c) 209,163 (3,840) 205,323 Total assets acquired $ 11,177,186 $ (87,795) $ 11,089,391 LIABILITIES Notes and bonds payable $ 3,991,300 $ — $ 3,991,300 Accounts payable and accrued liabilities 1,227,570 17,374 1,244,944 Liabilities of assets held for sale 28,677 (3,939) 24,738 Operating lease liabilities 173,948 10,173 184,121 Financing lease liabilities 10,720 (855) 9,865 Other liabilities 203,210 (8,909) 194,301 Total liabilities assumed $ 5,635,425 $ 13,844 $ 5,649,269 Net identifiable assets acquired $ 5,541,761 $ (101,639) $ 5,440,122 Non-controlling interest $ 110,702 $ — $ 110,702 Goodwill $ 145,404 $ 101,639 $ 247,043 (a) The weighted average amortization period for the acquired lease intangible assets is approximately 6 years. (b) Includes $15.9 million of contractual accounts receivable, which approximates fair value. (c) Includes $78.7 million of gross contractual real estate notes receivable, the fair value of which was $74.8 million, and the Company preliminarily expects to collect substantially all of the real estate notes receivable proceeds as of the Closing Date.

Real Estate Investments (Tables

Real Estate Investments (Tables)	6 Months Ended
	Jun. 30, 2023
Business Combination and Asset Acquisition [Abstract]
Schedule of Real Estate Acquisitions	The following table details the Company's real estate acquisition activity for the six months ended June 30, 2023: Dollars in thousands DATE ACQUIRED PURCHASE PRICE CASH 1 REAL OTHER 2 SQUARE FOOTAGE Tampa, FL 3/10/23 $ 31,500 $ 30,499 $ 30,596 $ (97) 115,867 1 Cash consideration excludes prorations of revenue and expense due to/from seller at the time of the acquisition. 2 Includes other assets acquired, liabilities assumed, and intangibles recognized at acquisition. Subsequent to June 30, 2023, the Company acquired the following property: Dollars in thousands DATE ACQUIRED PURCHASE PRICE SQUARE FOOTAGE Colorado Springs, CO 7/28/23 $ 11,450 42,770
Schedule of Equity Method Investments	The Company's investment in and loss recognized for the three and six months ended June 30, 2023 and 2022 related to its unconsolidated joint ventures accounted for under the equity method are shown in the table below: THREE MONTHS ENDED SIX MONTHS ENDED Dollars in thousands 2023 2022 2023 2022 Investments in unconsolidated joint ventures, beginning of period $ 327,746 $ 211,195 $ 327,248 $ 161,942 New investment during the period 1 — — 3,824 49,599 Equity loss recognized during the period (17) (307) (797) (652) Owner distributions (484) (107) (3,030) (108) Investments in unconsolidated joint ventures, end of period $ 327,245 $ 210,781 $ 327,245 $ 210,781 1 In 2023, this was an additional investment in an existing joint venture in which the Company owns a 40% ownership interest. The investment consisted of a sale of a property in Dallas, Texas to the joint venture. See 2023 Real Estate Asset Dispositions below for additional information.
Schedule of Real Estate Dispositions	The following table details the Company's dispositions for the six months ended June 30, 2023: Dollars in thousands DATE DISPOSED SALE PRICE CLOSING ADJUSTMENTS COMPANY-FINANCED MORTGAGE NOTES NET PROCEEDS NET REAL ESTATE INVESTMENT OTHER (INCLUDING RECEIVABLES) 1 GAIN/(IMPAIRMENT) SQUARE FOOTAGE Tampa, FL & Miami, FL 2 1/12/23 $ 93,250 $ (5,875) $ — $ 87,375 $ 87,302 $ (888) $ 961 224,037 Dallas, TX 3 1/30/23 19,210 (141) — 19,069 18,986 43 40 36,691 St. Louis, MO 2/10/23 350 (18) — 332 398 — (66) 6,500 Los Angeles, CA 3/23/23 21,000 (526) — 20,474 20,610 52 (188) 37,165 Los Angeles, CA 4 3/30/23 75,000 (8,079) (45,000) 21,921 88,624 (803) (20,900) 147,078 Los Angeles, CA 5 5/12/23 3,300 (334) — 2,966 3,268 — (302) — Albany, NY 6/30/23 10,000 (1,229) — 8,771 2,613 (1,040) 7,198 40,870 Total dispositions $ 222,110 $ (16,202) $ (45,000) $ 160,908 $ 221,801 $ (2,636) $ (13,257) 492,341 1 Includes straight-line rent receivables, leasing commissions and lease inducements. 2 Includes two properties, sold in two separate transactions to the same buyer on the same date. 3 The Company sold this property to a joint venture in which it retained a 40% interest. Sales price and square footage reflect the total sales price paid by the joint venture and total square footage of the property. 4 The Company entered into a mortgage note agreement with the buyer for $45 million. 5 The Company sold a land parcel totaling 0.34 acres. Subsequent to June 30, 2023, the Company disposed of the following property: Dollars in thousands DATE DISPOSED SALES PRICE SQUARE FOOTAGE Houston, TX 8/2/23 $ 8,320 57,170
Schedule of Assets and Liabilities Held for Sale	The table below reflects the assets and liabilities classified as held for sale as of June 30, 2023 and December 31, 2022: Dollars in thousands June 30, 2023 December 31, 2022 Balance Sheet data: Land $ 205 $ 1,700 Building and improvements 1,736 15,164 Lease intangibles 2,242 1,986 4,183 18,850 Accumulated depreciation (4,183) — Real estate assets held for sale, net — 18,850 Other assets, net 151 43 Assets held for sale, net $ 151 $ 18,893 Accounts payable and accrued liabilities $ 222 $ 282 Other liabilities — 155 Liabilities of assets held for sale $ 222 $ 437

Leases (Tables)

Leases (Tables)	6 Months Ended
	Jun. 30, 2023
Leases [Abstract]
Schedule of Future Minimum Operating Lease Payments Receivable	Future lease payments under the non-cancelable operating leases, excluding any reimbursements and the sale-type lease, as of June 30, 2023 were as follows: Dollars in thousands OPERATING 2023 $ 467,393 2024 861,323 2025 751,369 2026 648,352 2027 536,874 2028 and thereafter 1,950,019 $ 5,215,330
Schedule of Future Minimum Operating Lease Payments	The Company’s future lease payments (primarily for its 166 non-prepaid ground leases) as of June 30, 2023 were as follows: Dollars in thousands OPERATING FINANCING 2023 $ 7,315 $ 992 2024 15,011 2,182 2025 14,597 2,218 2026 14,631 2,255 2027 14,701 2,294 2028 and thereafter 929,853 396,398 Total undiscounted lease payments 996,108 406,339 Discount (717,629) (332,710) Lease liabilities $ 278,479 $ 73,629
Schedule of Future Minimum Financing Lease Payments	The Company’s future lease payments (primarily for its 166 non-prepaid ground leases) as of June 30, 2023 were as follows: Dollars in thousands OPERATING FINANCING 2023 $ 7,315 $ 992 2024 15,011 2,182 2025 14,597 2,218 2026 14,631 2,255 2027 14,701 2,294 2028 and thereafter 929,853 396,398 Total undiscounted lease payments 996,108 406,339 Discount (717,629) (332,710) Lease liabilities $ 278,479 $ 73,629
Schedule of Lease Cost	The following table provides details of the Company's total lease expense for the three and six months ended June 30, 2023 and 2022: THREE MONTHS ENDED SIX MONTHS ENDED Dollars in thousands 2023 2022 2023 2022 Operating lease cost Operating lease expense $ 5,329 $ 1,194 $ 10,436 $ 2,409 Variable lease expense 2,235 1,038 4,371 2,062 Finance lease cost Amortization of right-of-use assets 387 331 774 503 Interest on lease liabilities 923 765 1,841 1,052 Total lease expense $ 8,874 $ 3,328 $ 17,422 $ 6,026 Other information Operating cash flows outflows related to operating leases $ 5,230 $ 1,799 $ 11,190 $ 4,596 Operating cash flows outflows related to financing leases $ 541 $ 509 $ 1,094 $ 767 Financing cash flows outflows related to financing leases $ 6 $ — $ 17 $ 51 Right-of-use assets obtained in exchange for new finance lease liabilities $ — $ — $ — $ 40,589 Weighted-average years remaining lease term (excluding renewal options) - operating leases 47.3 47.4 Weighted-average years remaining lease term (excluding renewal options) - finance leases 58.4 61.7 Weighted-average discount rate - operating leases 5.8 % 5.6 % Weighted-average discount rate - finance leases 5.0 % 5.0 %

Notes and Bonds Payable (Tables

Notes and Bonds Payable (Tables)	6 Months Ended
	Jun. 30, 2023
Debt Disclosure [Abstract]
Schedule of Debt	The table below details the Company’s notes and bonds payable as of June 30, 2023 and December 31, 2022. MATURITY DATES BALANCE 1 AS OF EFFECTIVE INTEREST RATE Dollars in thousands 6/30/2023 12/31/2022 $1.5 billion Unsecured Credit Facility 10/25 $ 354,000 $ 385,000 6.05 % $350 million Unsecured Term Loan 2 7/24 349,499 349,114 6.21 % $200 million Unsecured Term Loan 5/24 199,786 199,670 6.21 % $300 million Unsecured Term Loan 10/25 299,947 299,936 6.21 % $150 million Unsecured Term Loan 6/26 149,569 149,495 6.21 % $200 million Unsecured Term Loan 7/27 199,432 199,362 6.21 % $300 million Unsecured Term Loan 1/28 298,079 297,869 6.21 % Senior Notes due 2025 5/25 249,298 249,115 4.12 % Senior Notes due 2026 8/26 575,256 571,587 4.94 % Senior Notes due 2027 7/27 481,615 479,553 4.76 % Senior Notes due 2028 1/28 297,138 296,852 3.85 % Senior Notes due 2030 2/30 570,356 565,402 5.30 % Senior Notes due 2030 3/30 296,579 296,385 2.72 % Senior Notes due 2031 3/31 295,795 295,547 2.25 % Senior Notes due 2031 3/31 640,999 632,693 5.13 % Mortgage notes payable 8/23-12/26 82,924 84,247 3.57%-4.84% $ 5,340,272 $ 5,351,827 . 1 Balance is presented net of discounts and issuance costs and inclusive of premiums, where applicable.

Derivative Financial Instrume_2

Derivative Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2023
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Schedule of Cash Flow Hedges Included in Accumulated Other Comprehensive Income (Loss)	As of June 30, 2023, the Company had 14 outstanding interest rate derivatives that were designated as cash flow hedges of interest rate risk: EXPIRATION DATE AMOUNT WEIGHTED January 15, 2024 $ 200,000 1.21 % May 1, 2026 100,000 2.15 % June 1, 2026 150,000 3.83 % December 1, 2026 150,000 3.84 % June 1, 2027 150,000 4.13 % December 1, 2027 250,000 3.79 % $ 1,000,000 3.17 % The table below presents the effect of cash flow hedge accounting on AOCI during the three and six months ended June 30, 2023 and 2022 related to the Company's outstanding interest rate swaps. (GAIN)/LOSS RECOGNIZED IN (GAIN)/LOSS RECLASSIFIED FROM In thousands 2023 2022 2023 2022 Interest rate swaps $ (21,523) $ (1,663) Interest expense $ (3,568) $ 674 Settled treasury hedges — — Interest expense 107 107 Settled interest rate swaps — — Interest expense 42 42 $ (21,523) $ (1,663) Total interest expense $ (3,419) $ 823 (GAIN)/LOSS RECOGNIZED IN (GAIN)/LOSS RECLASSIFIED FROM In thousands 2023 2022 2023 2022 Interest rate swaps $ (12,981) $ (6,822) Interest expense $ (6,000) $ 1,612 Settled treasury hedges — — Interest expense 213 213 Settled interest rate swaps — — Interest expense 84 84 $ (12,981) $ (6,822) Total interest expense $ (5,703) $ 1,909
Schedule of Derivative Instruments in Statement of Financial Position, Fair Value	The table below presents the fair value of the Company's derivative financial instruments, as well as their classification on the Condensed Consolidated Balance Sheet as of June 30, 2023. BALANCE AT JUNE 30, 2023 In thousands BALANCE SHEET LOCATION FAIR VALUE Derivatives designated as hedging instruments Interest rate swaps Other liabilities $ (1,248) Interest rate swaps Other assets $ 16,046 Total derivatives designated as hedging instruments $ 14,798

Stockholders' Equity (Tables)

Stockholders' Equity (Tables)	6 Months Ended
	Jun. 30, 2023
Equity [Abstract]
Schedule of Reconciliation of Common Stock Outstanding	The following table provides a reconciliation of the beginning and ending shares of common stock outstanding for the six months ended June 30, 2023 and the twelve months ended December 31, 2022: SIX MONTHS ENDED JUNE 30, 2023 TWELVE MONTHS ENDED DECEMBER 31, 2022 Balance, beginning of period 380,589,894 150,457,433 Issuance of common stock 4,817 229,618,304 Non-vested share-based awards, net of withheld shares 262,821 514,157 Balance, end of period 380,857,532 380,589,894
Schedule of Earnings (Loss) per Share	The following table sets forth the computation of basic and diluted earnings per common share for the three and six months ended June 30, 2023 and 2022. THREE MONTHS ENDED JUNE 30, SIX MONTHS ENDED JUNE 30, Dollars in thousands, except per share data 2023 2022 2023 2022 Weighted average common shares outstanding Weighted average common shares outstanding 380,829,011 151,620,897 380,812,981 151,230,064 Non-vested shares (1,932,334) (1,945,042) (1,952,350) (1,908,652) Weighted average common shares outstanding - basic 378,896,677 149,675,855 378,860,631 149,321,412 Weighted average common shares outstanding - basic 378,896,677 149,675,855 378,860,631 149,321,412 Dilutive effect of employee stock purchase plan — 62,694 — 75,394 Weighted average common shares outstanding - diluted 378,896,677 149,738,549 378,860,631 149,396,806 Net (loss) income attributable to common stockholders $ (82,759) $ 6,130 $ (169,884) $ 48,357 Dividends paid on nonvested share-based awards (588) (601) (1,193) (1,207) Net (loss) income applicable to common stockholders - basic $ (83,347) $ 5,529 $ (171,077) $ 47,150 Basic earnings per common share - net income $ (0.22) $ 0.04 $ (0.45) $ 0.32 Diluted earnings per common share - net income $ (0.22) $ 0.04 $ (0.45) $ 0.32
Summary of the Activity Under the Incentive Plan and Restricted Stock Unit	A summary of the activity under the Company's share-based incentive plans for the three and six months ended June 30, 2023 and 2022 is included in the table below. THREE MONTHS ENDED JUNE 30, SIX MONTHS ENDED JUNE 30, 2023 2022 2023 2022 Share-based awards, beginning of period 1,955,445 1,951,551 1,795,128 1,562,028 Granted 43,276 26,840 325,816 442,024 Vested (62,640) (36,682) (164,360) (61,047) Forfeited (3,860) — (24,363) (1,296) Share-based awards, end of period 1,932,221 1,941,709 1,932,221 1,941,709 The following is a summary of the RSU activity during the three and six months ended June 30, 2023: THREE MONTHS ENDED JUNE 30, SIX MONTHS ENDED JUNE 30, Restricted Stock Units Weighted Average Grant Date Fair Value Restricted Stock Units Weighted Average Grant Date Fair Value Non-vested, beginning of period 363,250 $ 28.57 294,932 33.04 Granted — — 165,174 $ 22.55 Vested/Forfeited — — (17,606) 33.04 Probability adjustment of 2022 RSUs — — (79,250) 31.68 Non-vested, end of period 363,250 $ 28.57 363,250 28.57
Schedule of Stock Options, Valuation Assumptions	THREE MONTHS ENDED MARCH 31, Volatility 34.0 % Dividend assumption Accrued Expected term 3 years Risk-free rate 4.42 % Stock price (per share) $20.21 THREE MONTHS ENDED MARCH 31, Volatility 34.0 % Dividend assumption Accrued Expected term 3 years Risk-free rate 4.42 % Stock price (per share) $20.21
Summary of Employee Stock Purchase Plan Activity	A summary of the activity under the ESPP for the three and six months ended June 30, 2023 and 2022 is included in the table below. THREE MONTHS ENDED JUNE 30, SIX MONTHS ENDED JUNE 30, 2023 2022 2023 2022 Outstanding and exercisable, beginning of period 183,426 427,802 340,976 348,514 Granted — — — 255,960 Exercised (1,687) (1,965) (4,817) (12,518) Forfeited (2,370) (20,303) (23,791) (45,789) Expired — — (132,999) (140,633) Outstanding and exercisable, end of period 179,369 405,534 179,369 405,534
Schedule of Unrecognized Compensation Cost, Nonvested Awards	The following table represents expected amortization of the Company's non-vested shares issued as of June 30, 2023: Dollars in millions FUTURE AMORTIZATION 2023 $ 7.7 2024 13.3 2025 10.8 2026 8.0 2027 2.4 2028 and thereafter 0.5 Total $ 42.7

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	6 Months Ended
	Jun. 30, 2023
Fair Value Disclosures [Abstract]
Schedule of Fair Value And Carrying Values For Notes And Bonds Payable, Real Estate Notes Receivable, And Notes Receivable	The table below details the fair values and carrying values for notes and bonds payable and real estate notes receivable at June 30, 2023 and December 31, 2022. June 30, 2023 December 31, 2022 Dollars in millions CARRYING VALUE FAIR VALUE CARRYING VALUE FAIR VALUE Notes and bonds payable 1 $ 5,340.3 $ 5,107.5 $ 5,351.8 $ 5,149.6 Real estate notes receivable 1 $ 151.5 $ 149.0 $ 99.6 $ 99.6 1 Level 2 – model-derived valuations in which significant inputs and significant value drivers are observable in active markets.

Summary of Significant Accoun_4

Summary of Significant Accounting Policies (Details) $ in Thousands, shares in Millions, ft² in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2023 USD ($) ft² financing_receivable variable_interest_entity property note_receivable state shares	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) ft² financing_receivable property variable_interest_entity note_receivable state joint_venture shares	Jun. 30, 2022 USD ($)	Dec. 31, 2022 USD ($)	Mar. 31, 2023 USD ($)	Mar. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)
Business Overview:
Gross investment amount, total	$ 13,900,000		$ 13,900,000
Number of real estate properties | property	680		680
Number of owned real estate properties | property	680		680
Number of states that the company owns real estate in, whole units | state	35		35
Approximate square feet invested in by company | ft²	39.8		39.8
Approximate square feet for which Nationwide property management services provided by company | ft²	39.3		39.3
Number of buildings owned by joint venture with TIAA | property	34		34
Principles of Consolidation:
Equity ownership for consolidation (percent)	100%		100%
Number of variable interest entities | variable_interest_entity	4		4
Redeemable Non-Controlling Interests:
Redeemable non-controlling interests	$ 2,487	$ 0	$ 2,487	$ 0	$ 2,014	$ 2,000	$ 0	$ 0
Asset Impairment:
Impairment of real estate assets	55,200		81,400
Real Estate Notes Receivable:
Investment in financing receivable, net	$ 151,500		151,500
Allowance for Credit Losses, Interest Income, Income from Real Estate Notes Receivable:
Credit loss reserves			$ 5,196		$ 0
Number of recognized lease financial receivables | financing_receivable	2		2
Income from financing receivables	$ 2,100	$ 2,000	$ 4,200	$ 3,900
Number of real estate notes receivable | financing_receivable	2		2
Financing receivable, nonaccrual	$ 48,900		$ 48,900
Notes Receivable
Allowance for Credit Losses, Interest Income, Income from Real Estate Notes Receivable:
Interest income	$ 2,200		$ 4,300
Variable Interest Entity
Principles of Consolidation:
Number of variable interest entities | variable_interest_entity	3		3
Number of notes receivable | note_receivable	2		2
Number of joint ventures | joint_venture			1
Non-Controlling Interest Holders | Healthcare Trustof America Holdings L P
Principles of Consolidation:
Limited partner's capital, units outstanding (in shares) | shares	4.7		4.7
Limited partners ownership interest (in percent)			1.20%
Property Entities Not Determined to be VIEs
Principles of Consolidation:
Equity interest owned (percent)	100%		100%
Healthcare Trustof America Holdings L P
Principles of Consolidation:
Equity interest owned (percent)	98.80%		98.80%
Real Estate Properties Held in Joint Ventures
Business Overview:
Joint venture ownership (percent)	44%		44%

Summary of Significant Accoun_5

Summary of Significant Accounting Policies - Consolidated balance sheets (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
Assets:
Net real estate investments	$ 11,900,027	$ 12,412,354
Cash and cash equivalents	35,904	60,961
Total assets	13,394,347	13,849,631
Liabilities:
Total equity	7,179,399	7,571,076
Total liabilities and equity	13,394,347	$ 13,849,631
Variable interest entity
Assets:
Net real estate investments	61,980
Cash and cash equivalents	2,107
Receivables and other assets	2,015
Total assets	66,102
Liabilities:
Accrued expenses and other liabilities	14,058
Total equity	52,044
Total liabilities and equity	$ 66,102

Summary of Significant Accoun_6

Summary of Significant Accounting Policies - Variable interest entity (Details) $ in Thousands	Jun. 30, 2023 USD ($) property note_receivable
Variable Interest Entity [Line Items]
Number of owned real estate properties | property	680
Variable Interest Entity
Variable Interest Entity [Line Items]
Number of notes receivable | note_receivable	2
Houston, TX | Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Notes receivable, carrying amount	$ 30,445
MAXIMUM EXPOSURE TO LOSS	31,150
North Carolina | Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Notes receivable, carrying amount	5,691
MAXIMUM EXPOSURE TO LOSS	6,000
Texas | Variable Interest Entity, Not Primary Beneficiary
Variable Interest Entity [Line Items]
Joint venture, carrying amount	64,758
MAXIMUM EXPOSURE TO LOSS	$ 64,758
Number of owned real estate properties | property	7

Summary of Significant Accoun_7

Summary of Significant Accounting Policies - Schedule of Notes Receivable (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022	Dec. 31, 2021
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, carrying value	$ 121,315
MAXIMUM LOAN COMMITMENT	201,269
REAL ESTATE NOTES RECEIVABLE, GROSS	160,825
ALLOWANCE FOR CREDIT LOSSES	(5,196)	$ 0	$ 0
FAIR VALUE DISCOUNT AND FEES	(4,136)
CARRYING VALUE	151,493
Mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
MAXIMUM LOAN COMMITMENT	147,150
REAL ESTATE NOTES RECEIVABLE, GROSS	106,706
ALLOWANCE FOR CREDIT LOSSES	0
FAIR VALUE DISCOUNT AND FEES	(1,069)
CARRYING VALUE	105,637
Poway, CA
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, carrying value	$ 113,967
STATED INTEREST RATE	5.73%
Columbus, OH
Accounts, Notes, Loans and Financing Receivable [Line Items]
Financing receivable, carrying value	$ 7,348
STATED INTEREST RATE	6.48%
Texas | Mezzanine loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	8%
MAXIMUM LOAN COMMITMENT	$ 54,119
REAL ESTATE NOTES RECEIVABLE, GROSS	54,119
ALLOWANCE FOR CREDIT LOSSES	(5,196)
FAIR VALUE DISCOUNT AND FEES	(3,067)
CARRYING VALUE	$ 45,856
Texas | Mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	7%
MAXIMUM LOAN COMMITMENT	$ 31,150
REAL ESTATE NOTES RECEIVABLE, GROSS	31,150
ALLOWANCE FOR CREDIT LOSSES	0
FAIR VALUE DISCOUNT AND FEES	(705)
CARRYING VALUE	$ 30,445
North Carolina | Mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	8%
MAXIMUM LOAN COMMITMENT	$ 6,000
REAL ESTATE NOTES RECEIVABLE, GROSS	6,000
ALLOWANCE FOR CREDIT LOSSES	0
FAIR VALUE DISCOUNT AND FEES	(309)
CARRYING VALUE	$ 5,691
Florida | Mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	6%
MAXIMUM LOAN COMMITMENT	$ 65,000
REAL ESTATE NOTES RECEIVABLE, GROSS	24,556
ALLOWANCE FOR CREDIT LOSSES	0
FAIR VALUE DISCOUNT AND FEES	(55)
CARRYING VALUE	$ 24,501
California | Mortgage loans
Accounts, Notes, Loans and Financing Receivable [Line Items]
STATED INTEREST RATE	6%
MAXIMUM LOAN COMMITMENT	$ 45,000
REAL ESTATE NOTES RECEIVABLE, GROSS	45,000
ALLOWANCE FOR CREDIT LOSSES	0
FAIR VALUE DISCOUNT AND FEES	0
CARRYING VALUE	$ 45,000

Summary of Significant Accoun_8

Summary of Significant Accounting Policies - Schedule of Company's Allowance For Credit Losses (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for credit losses, beginning of period	$ 0	$ 0
Credit loss reserves	5,196	0
Allowance for credit losses, end of period	$ 5,196	$ 0

Summary of Significant Accoun_9

Summary of Significant Accounting Policies - Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Disaggregation of Revenue [Line Items]
Type of Revenue	$ 4,230	$ 2,738	$ 8,847	$ 5,213
Parking income
Disaggregation of Revenue [Line Items]
Type of Revenue	2,370	1,919	4,761	3,672
Management fee income
Disaggregation of Revenue [Line Items]
Type of Revenue	1,597	783	3,570	1,438
Miscellaneous
Disaggregation of Revenue [Line Items]
Type of Revenue	$ 263	$ 36	$ 516	$ 103

Merger with HTA - Narrative (De

Merger with HTA - Narrative (Details) - USD ($)		3 Months Ended		6 Months Ended		12 Months Ended
	Jul. 20, 2022	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Dec. 31, 2022
Business Acquisition [Line Items]
Common stock, par value (in dollars per share)		$ 0.01		$ 0.01		$ 0.01
Goodwill	$ 247,043,000	$ 250,530,000		$ 250,530,000		$ 223,202,000
Goodwill expected to be tax deductible	0
Merger-related costs		$ (15,670,000)	$ 7,085,000	$ (10,815,000)	$ 13,201,000
Refund of transfer taxes paid						$ 17,800,000
Revision of Prior Period, Adjustment
Business Acquisition [Line Items]
Goodwill adjustment incomplete	$ 101,600,000
HealthCare Realty Trust Incorporated | Common Class A
Business Acquisition [Line Items]
Common stock, par value (in dollars per share)	$ 0.01
HealthCare Realty Trust, Inc.
Business Acquisition [Line Items]
Common stock, par value (in dollars per share)	0.01
Healthcare Trust Of America, Inc
Business Acquisition [Line Items]
Common stock, par value (in dollars per share)	$ 0.01
Conversion ratio	1
Dividends declared per common share, during the period (in dollars per share)	$ 4.82

Merger with HTA (Details)

Merger with HTA (Details)		6 Months Ended
	Jul. 20, 2022 USD ($) $ / shares shares	Jun. 30, 2023 USD ($) shares	Dec. 31, 2022 shares
Business Acquisition [Line Items]
Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)	228,857,717	380,858,000	380,590,000
Implied shares of Legacy HR Common Stock issued (in shares)	228,520,990
Adjusted closing price of Legacy HR Common Stock on July 20, 2022 (in dollars per share) | $ / shares	$ 24.37
Value of implied Legacy HR Common Stock issued | $	$ 5,569,057,000
Fair value of Legacy HTA restricted stock awards attributable to pre-Merger services | $		$ 7,406,000
Consideration transferred | $		$ 5,576,463,000
Healthcare Trust Of America, Inc
Business Acquisition [Line Items]
Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)	228,520,990
Exchange ratio	1
Common Stock, fractional (in shares)	192
Healthcare Trust Of America, Inc | Restricted stock
Business Acquisition [Line Items]
Shares of Legacy HTA Common Stock outstanding as of July 20, 2022 as adjusted (in shares)	336,535
Common Stock, withheld (in shares)	215,764

Merger with HTA - Schedule of F

Merger with HTA - Schedule of Fair Values of the Assets Acquired And Liabilities Assumed (Details) - USD ($) $ in Thousands	Jul. 20, 2022	Jun. 30, 2023	Dec. 31, 2022
Real estate investments
Land	$ 1,004,285
Buildings and improvements	6,841,283
Lease intangible assets	833,759
Financing lease right-of-use assets	13,020
Construction in progress	3,327
Land held for development	46,538
Total real estate investments	8,742,212
Assets held for sale, net	699,496
Investments in unconsolidated joint ventures	67,892
Cash and cash equivalents	37,437
Restricted cash	1,122,400
Operating lease right-of-use assets	214,631
Other assets, net	205,323
Total assets acquired	11,089,391
LIABILITIES
Notes and bonds payable	3,991,300
Accounts payable and accrued liabilities	1,244,944
Liabilities of assets held for sale	24,738
Operating lease liabilities	184,121
Financing lease liabilities	9,865
Other liabilities	194,301
Total liabilities assumed	5,649,269
Net identifiable assets acquired	5,440,122
Non-controlling interest	110,702
Goodwill	$ 247,043	$ 250,530	$ 223,202
Weighted average amortization period for the acquired lease intangible assets	6 years
Gross contractual accounts receivable	$ 15,900
Gross contractual real estate notes receivable	78,700
Gross contractual real estate notes receivable at fair value	74,800
CUMULATIVE MEASUREMENT PERIOD ADJUSTMENTS
Land	18,359
Buildings and improvements	(119,135)
Lease intangible assets	1,839
Financing lease right-of-use assets	3,146
Construction in progress	(6,744)
Total real estate investments	(102,535)
Assets held for sale, net	(7,946)
Cash and cash equivalents	11,403
Restricted cash	(1,247)
Operating lease right-of-use assets	16,370
Other assets, net	(3,840)
Total assets acquired	(87,795)
Accounts payable and accrued liabilities	17,374
Liabilities of assets held for sale	(3,939)
Operating lease liabilities	10,173
Financing lease liabilities	(855)
Other liabilities	(8,909)
Total liabilities assumed	13,844
Net identifiable assets acquired	(101,639)
Goodwill	101,639
Previously Reported
Real estate investments
Land	985,926
Buildings and improvements	6,960,418
Lease intangible assets	831,920
Financing lease right-of-use assets	9,874
Construction in progress	10,071
Land held for development	46,538
Total real estate investments	8,844,747
Assets held for sale, net	707,442
Investments in unconsolidated joint ventures	67,892
Cash and cash equivalents	26,034
Restricted cash	1,123,647
Operating lease right-of-use assets	198,261
Other assets, net	209,163
Total assets acquired	11,177,186
LIABILITIES
Notes and bonds payable	3,991,300
Accounts payable and accrued liabilities	1,227,570
Liabilities of assets held for sale	28,677
Operating lease liabilities	173,948
Financing lease liabilities	10,720
Other liabilities	203,210
Total liabilities assumed	5,635,425
Net identifiable assets acquired	5,541,761
Non-controlling interest	110,702
Goodwill	$ 145,404

Real Estate Investments -Real E

Real Estate Investments -Real Estate Acquisitions (Details) $ in Thousands			6 Months Ended
	Jul. 28, 2023 USD ($) ft²	Mar. 10, 2023 USD ($) ft²	Jun. 30, 2023 USD ($)
Business Acquisition [Line Items]
PURCHASE PRICE			$ 5,576,463
Tampa, FL | Medical office building
Business Acquisition [Line Items]
PURCHASE PRICE		$ 31,500
CASH CONSIDERATION		30,499
REAL ESTATE		30,596
OTHER		$ (97)
SQUARE FOOTAGE | ft²		115,867
Colorado Springs, CO | Medical office building | Subsequent event
Business Acquisition [Line Items]
PURCHASE PRICE	$ 11,450
SQUARE FOOTAGE | ft²	42,770

Real Estate Investments - Narra

Real Estate Investments - Narrative (Details) - Medical office building - Scottsdale, Arizona $ in Millions	3 Months Ended
	Jun. 30, 2023 USD ($)
Business Acquisition [Line Items]
Joint venture, ownership (in percentage)	90%
Joint venture acquired	$ 8.8
Cash consideration	$ 8.3

Real Estate Investments - Uncon

Real Estate Investments - Unconsolidated Joint Venture Acquisitions (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Equity Method Investments [Roll Forward]
Investments in unconsolidated joint ventures, beginning of period			$ 327,248
Equity loss recognized during the period	$ (17)	$ (307)	(797)	$ (652)
Investments in unconsolidated joint ventures, end of period	327,245		327,245
Parking Garages
Equity Method Investments [Roll Forward]
Investments in unconsolidated joint ventures, beginning of period	327,746	211,195	327,248	161,942
New investments during the period	0	0	3,824	49,599
Equity loss recognized during the period	(17)	(307)	(797)	(652)
Owner distributions	(484)	(107)	(3,030)	(108)
Investments in unconsolidated joint ventures, end of period	$ 327,245	$ 210,781	$ 327,245	$ 210,781
Parking Garages | Los Angeles, CA | Limited Liability Company One
Equity Method Investments [Roll Forward]
Joint venture, ownership (in percentage)			40%

Real Estate Investments - Dispo

Real Estate Investments - Dispositions (Details) $ in Thousands								6 Months Ended
	Jun. 30, 2023 USD ($) ft² property	May 12, 2023 USD ($) ft² a	Mar. 30, 2023 USD ($) ft²	Mar. 23, 2023 USD ($) ft²	Feb. 10, 2023 USD ($) ft²	Jan. 30, 2023 USD ($) ft²	Jan. 12, 2023 USD ($) ft² property disposition_transaction	Jun. 30, 2023 USD ($) ft² property	Aug. 02, 2023 USD ($) ft²
Real Estate Dispositions [Line Items]
Number of owned real estate properties | property	680							680
Real Estate Dispositions
Real Estate Dispositions [Line Items]
SALE PRICE	$ 222,110							$ 222,110
CLOSING ADJUSTMENTS	(16,202)							(16,202)
COMPANY-FINANCED MORTGAGE NOTES	(45,000)							(45,000)
NET PROCEEDS								160,908
NET REAL ESTATE INVESTMENT	221,801							221,801
OTHER (INCLUDING RECEIVABLES)	$ (2,636)							(2,636)
GAIN/(IMPAIRMENT)								$ (13,257)
SQUARE FOOTAGE | ft²	492,341							492,341
Tampa Fl & Miami FL
Real Estate Dispositions [Line Items]
SALE PRICE							$ 93,250
CLOSING ADJUSTMENTS							(5,875)
COMPANY-FINANCED MORTGAGE NOTES							0
NET PROCEEDS							87,375
NET REAL ESTATE INVESTMENT							87,302
OTHER (INCLUDING RECEIVABLES)							(888)
GAIN/(IMPAIRMENT)							$ 961
SQUARE FOOTAGE | ft²							224,037
Number of owned real estate properties | property							2
Number of property dispositions | disposition_transaction							2
Dallas, TX
Real Estate Dispositions [Line Items]
SALE PRICE						$ 19,210
CLOSING ADJUSTMENTS						(141)
COMPANY-FINANCED MORTGAGE NOTES						0
NET PROCEEDS						19,069
NET REAL ESTATE INVESTMENT						18,986
OTHER (INCLUDING RECEIVABLES)						43
GAIN/(IMPAIRMENT)						$ 40
SQUARE FOOTAGE | ft²						36,691
Joint venture, ownership (in percentage)						40%
St. Louis, MO
Real Estate Dispositions [Line Items]
SALE PRICE					$ 350
CLOSING ADJUSTMENTS					(18)
COMPANY-FINANCED MORTGAGE NOTES					0
NET PROCEEDS					332
NET REAL ESTATE INVESTMENT					398
OTHER (INCLUDING RECEIVABLES)					0
GAIN/(IMPAIRMENT)					$ (66)
SQUARE FOOTAGE | ft²					6,500
Los Angeles, CA
Real Estate Dispositions [Line Items]
SALE PRICE		$ 3,300	$ 75,000	$ 21,000
CLOSING ADJUSTMENTS		(334)	(8,079)	(526)
COMPANY-FINANCED MORTGAGE NOTES		0	(45,000)	0
NET PROCEEDS		2,966	21,921	20,474
NET REAL ESTATE INVESTMENT		3,268	88,624	20,610
OTHER (INCLUDING RECEIVABLES)		0	(803)	52
GAIN/(IMPAIRMENT)		$ (302)	$ (20,900)	$ (188)
SQUARE FOOTAGE | ft²		0	147,078	37,165
Mortgage note			$ 45,000
Albany, NY
Real Estate Dispositions [Line Items]
SALE PRICE	$ 10,000							$ 10,000
CLOSING ADJUSTMENTS	(1,229)							(1,229)
COMPANY-FINANCED MORTGAGE NOTES	0							0
NET PROCEEDS	8,771
NET REAL ESTATE INVESTMENT	2,613							2,613
OTHER (INCLUDING RECEIVABLES)	(1,040)							$ (1,040)
GAIN/(IMPAIRMENT)	$ 7,198
SQUARE FOOTAGE | ft²	40,870							40,870
Area of land | a		0.34
Houston, TX | Subsequent event
Real Estate Dispositions [Line Items]
SALE PRICE									$ 8,320
SQUARE FOOTAGE | ft²									57,170

Real Estate Investments - Asset

Real Estate Investments - Assets Held for Sale (Details) $ in Thousands	6 Months Ended
	Jun. 30, 2023 USD ($) property	Dec. 31, 2022 USD ($) property
Long Lived Assets Held-for-sale [Line Items]
Number of properties classified as held for sale | property	3	1
Impairment charges on net real estate assets held for sale	$ 3,600
Land	1,424,453	$ 1,439,798
Building and improvements	11,188,821	11,332,037
Real estate investment property, at cost	13,883,971	14,057,625
Accumulated depreciation	(1,983,944)	(1,645,271)
Real estate assets held for sale, net	11,900,027	12,412,354
Assets held for sale, net	151	18,893
Liabilities of assets held for sale	222	437
Disposal Group, Held-for-sale, Not Discontinued Operations
Long Lived Assets Held-for-sale [Line Items]
Land	205	1,700
Building and improvements	1,736	15,164
Lease intangibles	2,242	1,986
Real estate investment property, at cost	4,183	18,850
Accumulated depreciation	(4,183)	0
Real estate assets held for sale, net	0	18,850
Other assets, net	151	43
Assets held for sale, net	151	18,893
Accounts payable and accrued liabilities	222	282
Other liabilities	0	155
Liabilities of assets held for sale	$ 222	$ 437

Leases - Lease Income (Details)

Leases - Lease Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Leases [Abstract]
Rental income	$ 329,680	$ 140,632	$ 653,773	$ 279,121

Leases - Lessor Accounting (Det

Leases - Lessor Accounting (Details) $ in Thousands	Jun. 30, 2023 USD ($)
Future Operating Lease Payments Receivable [Abstract]
2023	$ 467,393
2024	861,323
2025	751,369
2026	648,352
2027	536,874
2028 and thereafter	1,950,019
Total	$ 5,215,330

Leases - Ground Leases (Details

Leases - Ground Leases (Details) ft² in Millions, $ in Millions	3 Months Ended		6 Months Ended
	Jun. 30, 2023 USD ($) lease property	Jun. 30, 2022 USD ($)	Jun. 30, 2023 USD ($) ft² lease property	Jun. 30, 2022 USD ($)
Lessee, Lease, Description [Line Items]
Number of properties subject to ground leases | property	241		241
Square feet subject to ground leases | ft²			17.5
Number of prepaid ground leases			75
Amortization of prepaid rent | $	$ 0.3	$ 0.1	$ 0.7	$ 0.3
Number of non-prepaid ground leases	166		166
Minimum
Lessee, Lease, Description [Line Items]
Ground lease, initial term	40 years		40 years
Maximum
Lessee, Lease, Description [Line Items]
Ground lease, initial term	99 years		99 years

Leases - Future Minimum Lease P

Leases - Future Minimum Lease Payments (Details) - USD ($) $ in Thousands	Jun. 30, 2023	Dec. 31, 2022
OPERATING
2023	$ 7,315
2024	15,011
2025	14,597
2026	14,631
2027	14,701
2028 and thereafter	929,853
Total undiscounted lease payments	996,108
Discount	(717,629)
Lease liabilities	278,479	$ 279,895
FINANCING
2023	992
2024	2,182
2025	2,218
2026	2,255
2027	2,294
2028 and thereafter	396,398
Total undiscounted lease payments	406,339
Discount	(332,710)
Lease liabilities	$ 73,629	$ 72,939

Leases - Lease Cost (Details)

Leases - Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Operating lease cost
Operating lease expense	$ 5,329	$ 1,194	$ 10,436	$ 2,409
Variable lease expense	2,235	1,038	4,371	2,062
Finance lease cost
Amortization of right-of-use assets	387	331	774	503
Interest on lease liabilities	923	765	1,841	1,052
Total lease expense	8,874	3,328	17,422	6,026
Other information
Operating cash flows outflows related to operating leases	5,230	1,799	11,190	4,596
Operating cash flows outflows related to financing leases	541	509	1,094	767
Financing cash flows outflows related to financing leases	6	0	17	51
Right-of-use assets obtained in exchange for new finance lease liabilities	$ 0	$ 0	$ 0	$ 40,589
Weighted-average years remaining lease term (excluding renewal options) - operating leases	47 years 3 months 18 days	47 years 4 months 24 days	47 years 3 months 18 days	47 years 4 months 24 days
Weighted-average years remaining lease term (excluding renewal options) - finance leases	58 years 4 months 24 days	61 years 8 months 12 days	58 years 4 months 24 days	61 years 8 months 12 days
Weighted-average discount rate - operating leases	5.80%	5.60%	5.80%	5.60%
Weighted-average discount rate - finance leases	5%	5%	5%	5%

Notes and Bonds Payable (Detail

Notes and Bonds Payable (Details) - USD ($)	Apr. 26, 2023	Jun. 30, 2023	Dec. 31, 2022
Debt Instrument [Line Items]
Notes and bonds payable		$ 5,340,272,000	$ 5,351,827,000
Extension period for maturity date	1 year
Debt fees	$ 400,000
Mortgage notes payable | Minimum
Debt Instrument [Line Items]
Effective interest rate		3.57%
Mortgage notes payable | Maximum
Debt Instrument [Line Items]
Effective interest rate		4.84%
Line of credit | $1.5 billion Unsecured Credit Facility
Debt Instrument [Line Items]
Notes and bonds payable		$ 354,000,000	385,000,000
Effective interest rate		6.05%
Credit facility		$ 1,500,000,000
Medium-term notes | $350 million Unsecured Term Loan due 2023, net of issuance costs
Debt Instrument [Line Items]
Notes and bonds payable		$ 349,499,000	349,114,000
Effective interest rate		6.21%
Face amount		$ 350,000,000
Medium-term notes | $200 million Unsecured Term Loan due 2024, net of issuance costs
Debt Instrument [Line Items]
Notes and bonds payable		$ 199,786,000	199,670,000
Effective interest rate		6.21%
Face amount		$ 200,000,000
Medium-term notes | $300 million Unsecured Term Loan due 2025, net of issuance costs
Debt Instrument [Line Items]
Notes and bonds payable		$ 299,947,000	299,936,000
Effective interest rate		6.21%
Face amount		$ 300,000,000
Medium-term notes | $150 million Unsecured Term Loan due 2026, net of issuance costs
Debt Instrument [Line Items]
Notes and bonds payable		$ 149,569,000	149,495,000
Effective interest rate		6.21%
Face amount		$ 150,000,000
Medium-term notes | $200 million Unsecured Term Loan due 2027, net of issuance costs
Debt Instrument [Line Items]
Notes and bonds payable		$ 199,432,000	199,362,000
Effective interest rate		6.21%
Face amount		$ 200,000,000
Medium-term notes | $300 million Unsecured Term Loan due 2028, net of issuance costs
Debt Instrument [Line Items]
Notes and bonds payable		$ 298,079,000	297,869,000
Effective interest rate		6.21%
Face amount		$ 300,000,000
Senior notes | Senior Notes due 2025, net of discount and issuance costs
Debt Instrument [Line Items]
Notes and bonds payable		$ 249,298,000	249,115,000
Effective interest rate		4.12%
Senior notes | Senior Notes due 2026, net of discount and issuance costs
Debt Instrument [Line Items]
Notes and bonds payable		$ 575,256,000	571,587,000
Effective interest rate		4.94%
Senior notes | Senior Notes due 2027, net of discount and issuance costs
Debt Instrument [Line Items]
Notes and bonds payable		$ 481,615,000	479,553,000
Effective interest rate		4.76%
Senior notes | Senior Notes due 2028
Debt Instrument [Line Items]
Notes and bonds payable		$ 297,138,000	296,852,000
Effective interest rate		3.85%
Senior notes | Senior notes due 2030, net of discount and issuance costs
Debt Instrument [Line Items]
Notes and bonds payable		$ 570,356,000	565,402,000
Effective interest rate		5.30%
Senior notes | Senior notes due 2030, net of discount and issuance costs
Debt Instrument [Line Items]
Notes and bonds payable		$ 296,579,000	296,385,000
Effective interest rate		2.72%
Senior notes | Senior Notes due 2031, net of discount and issuance costs
Debt Instrument [Line Items]
Notes and bonds payable		$ 295,795,000	295,547,000
Effective interest rate		2.25%
Senior notes | Senior Notes due 2031
Debt Instrument [Line Items]
Notes and bonds payable		$ 640,999,000	632,693,000
Effective interest rate		5.13%
Mortgages | Mortgage notes payable
Debt Instrument [Line Items]
Notes and bonds payable		$ 82,924,000	$ 84,247,000

Notes and Bonds Payable - Narra

Notes and Bonds Payable - Narrative (Details) - Mortgages - Subsequent event $ in Millions	Aug. 01, 2023 USD ($) ft²
Debt Instrument [Line Items]
Effective interest rate	3.31%
Outstanding principal repaid | $	$ 9.8
GEORGIA
Debt Instrument [Line Items]
Encumbered square footage | ft²	66,984

Derivative Financial Instrume_3

Derivative Financial Instruments - Cash Flow Hedges of Interest Rate Risk (Details) $ in Thousands	Jun. 30, 2023 USD ($) derivative
Derivative [Line Items]
Number of instruments | derivative	14
Interest Rate Swaps | Cash flow hedging | Designated as hedging instrument
Derivative [Line Items]
AMOUNT	$ 1,000,000
Weighted average interest rate (percent)	3.17%
Interest Rate Swap, Expiring January 15, 2024 | Cash flow hedging | Designated as hedging instrument
Derivative [Line Items]
AMOUNT	$ 200,000
Weighted average interest rate (percent)	1.21%
Interest Rate Swap, Expiring May 1, 2026 | Cash flow hedging | Designated as hedging instrument
Derivative [Line Items]
AMOUNT	$ 100,000
Weighted average interest rate (percent)	2.15%
Interest Rate Swap, Expiring June 1, 2026 | Cash flow hedging | Designated as hedging instrument
Derivative [Line Items]
AMOUNT	$ 150,000
Weighted average interest rate (percent)	3.83%
Interest Rate Swap, Expiring December 1, 2026 | Cash flow hedging | Designated as hedging instrument
Derivative [Line Items]
AMOUNT	$ 150,000
Weighted average interest rate (percent)	3.84%
Interest Rate Swap, Expiring June 1, 2027 | Cash flow hedging | Designated as hedging instrument
Derivative [Line Items]
AMOUNT	$ 150,000
Weighted average interest rate (percent)	4.13%
Interest Rate Swap, Expiring December 1, 2027 | Cash flow hedging | Designated as hedging instrument
Derivative [Line Items]
AMOUNT	$ 250,000
Weighted average interest rate (percent)	3.79%

Derivative Financial Instrume_4

Derivative Financial Instruments - Fair Value of Derivative Instruments on the Balance Sheet (Details) - Designated as hedging instrument $ in Thousands	Jun. 30, 2023 USD ($)
Settled interest rate swaps
Derivative [Line Items]
Liability derivatives	$ 14,798
Other liabilities | Interest rate swaps
Derivative [Line Items]
Liability derivatives	(1,248)
Other assets | Interest rate swaps
Derivative [Line Items]
Liability derivatives	$ 16,046

Derivative Financial Instrume_5

Derivative Financial Instruments - Effect of Cash Flow Hedging on AOCI (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Derivative [Line Items]
(Gain)/loss recognized in AOCI on derivative	$ (21,523)	$ (1,663)	$ (12,981)	$ (6,822)
Gain (Loss), Reclassified from AOCI into income	(3,419)	823	(5,703)	1,909
Interest expense
Derivative [Line Items]
Gain (Loss), Reclassified from AOCI into income	(3,419)	823	(5,703)	1,909
Interest rate swaps
Derivative [Line Items]
(Gain)/loss recognized in AOCI on derivative	(21,523)	(1,663)	(12,981)	(6,822)
Interest rate swaps | Interest expense
Derivative [Line Items]
Gain (Loss), Reclassified from AOCI into income	(3,568)	674	(6,000)	1,612
Settled treasury hedges
Derivative [Line Items]
(Gain)/loss recognized in AOCI on derivative	0	0	0	0
Settled treasury hedges | Interest expense
Derivative [Line Items]
Gain (Loss), Reclassified from AOCI into income	107	107	213	213
Settled interest rate swaps
Derivative [Line Items]
(Gain)/loss recognized in AOCI on derivative	0	0	0	0
Settled interest rate swaps | Interest expense
Derivative [Line Items]
Gain (Loss), Reclassified from AOCI into income	$ 42	$ 42	$ 84	$ 84

Derivative Financial Instrume_6

Derivative Financial Instruments - Derivative Instruments Designated as Cash Flow Hedges (Details) $ in Millions	Jun. 30, 2023 USD ($)
Derivative [Line Items]
Derivatives in net asset position	$ 15.4
Active Interest Rate Swap
Derivative [Line Items]
Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months	14.4
Settled Interest Rate Swaps
Derivative [Line Items]
Interest rate cash flow hedge gain (loss) to be reclassified to interest expense during the next 12 months	$ 0.6

Commitment and Contingencies -

Commitment and Contingencies - Narrative (Details) $ in Millions	6 Months Ended
	Jun. 30, 2023 USD ($)
Commitments and Contingencies Disclosure [Abstract]
Construction activity and development properties	$ 49

Stockholders' Equity - Reconcil

Stockholders' Equity - Reconciliation of Beginning and Ending Common Stock Outstanding (Details) - shares	6 Months Ended	12 Months Ended
	Jun. 30, 2023	Dec. 31, 2022
Reconciliation of the beginning and ending common stock outstanding
Balance, beginning of period (in shares)	380,590,000
Balance, end of period (in shares)	380,858,000	380,590,000
Common Stock
Reconciliation of the beginning and ending common stock outstanding
Balance, beginning of period (in shares)	380,589,894	150,457,433
Issuance of common stock (in shares)	4,817	229,618,304
Non-vested share-based awards, net of withheld shares (in shares)	262,821	514,157
Balance, end of period (in shares)	380,857,532	380,589,894

Stockholders' Equity (Stock Tra

Stockholders' Equity (Stock Transactions - Narrative) (Details)			1 Months Ended		3 Months Ended			6 Months Ended
	Aug. 01, 2023 $ / shares	Jan. 04, 2023 USD ($) $ / shares shares	Jan. 31, 2023	Jan. 31, 2022 $ / shares	Jun. 30, 2023 USD ($) director $ / shares shares	Mar. 31, 2023 USD ($) shares	Jun. 30, 2022 $ / shares shares	Jun. 30, 2023 USD ($) director $ / shares shares	Jun. 30, 2022 $ / shares shares
Class of Stock [Line Items]
Dividends paid per common share, during the period (in dollars per share) | $ / shares					$ 0.31		$ 0.31	$ 0.62	$ 0.62
Award vesting period								3 years
Subsequent event
Class of Stock [Line Items]
Dividends declared per common share, during the period (in dollars per share) | $ / shares	$ 0.31
Executive Incentive Program | Directors | Share-Based Payment Arrangement, Nonemployee
Class of Stock [Line Items]
Grant date fair value | $		$ 7,100,000
Stock incentive plan
Class of Stock [Line Items]
Granted (in shares)					43,276		26,840	325,816	442,024
Operating Partnership Performance Units
Class of Stock [Line Items]
Percentage of restricted stock units		43%
Weighted average grant date fair value (in dollars per share) | $ / shares		$ 15.85
Award performance period			3 years
Operating Partnership Performance Units | Performance conditions
Class of Stock [Line Items]
Percentage of restricted stock units		57%
Weighted average grant date fair value (in dollars per share) | $ / shares		$ 20.21
Operating Partnership Performance Units | Absolute TSR Component
Class of Stock [Line Items]
Weighted average grant date fair value (in dollars per share) | $ / shares				$ 12.24
Operating Partnership Performance Units | Relative TSR Component
Class of Stock [Line Items]
Weighted average grant date fair value (in dollars per share) | $ / shares				13.98
Operating Partnership Performance Units | Executive Incentive Program | Share-Based Payment Arrangement, Nonemployee
Class of Stock [Line Items]
Granted (in shares)		448,249
Award vesting period		5 years
Non-vested Stock Award | Executive Incentive Program
Class of Stock [Line Items]
Grant date fair value | $						$ 5,400,000
Granted (in shares)						270,494
Non-vested Stock Award | Executive Incentive Program | Directors
Class of Stock [Line Items]
Grant date fair value | $					$ 700,000
Granted (in shares)					42,768
Non-vested Stock Award | Executive Incentive Program | Minimum
Class of Stock [Line Items]
Award vesting period						3 years
Non-vested Stock Award | Executive Incentive Program | Maximum
Class of Stock [Line Items]
Award vesting period						8 years
Non-vested Stock Award | LTIP-D | Directors
Class of Stock [Line Items]
Grant date fair value | $					$ 1,100,000
Granted (in shares)					57,868
Number of directors | director					12			12
Non-vested Stock Award | LTIP-D | New Employee
Class of Stock [Line Items]
Granted (in shares)					508
Restricted stock | Stock incentive plan
Class of Stock [Line Items]
Shares withheld to pay estimated withholding taxes (in shares)								38,632	6,727
Restricted Stock Units (RSUs)
Class of Stock [Line Items]
Granted (in shares)					0			165,174
Award vesting period		5 years
Percentage of restricted stock units		43%
Weighted average grant date fair value (in dollars per share) | $ / shares		$ 22.55
Restricted Stock Units (RSUs) | Performance conditions
Class of Stock [Line Items]
Percentage of restricted stock units		57%
Weighted average grant date fair value (in dollars per share) | $ / shares		$ 20.21
Restricted Stock Units (RSUs) | Absolute TSR Component
Class of Stock [Line Items]
Weighted average grant date fair value (in dollars per share) | $ / shares				24.23
Restricted Stock Units (RSUs) | Relative TSR Component
Class of Stock [Line Items]
Weighted average grant date fair value (in dollars per share) | $ / shares				$ 27.84
Restricted Stock Units (RSUs) | Executive Incentive Program
Class of Stock [Line Items]
Grant date fair value | $		$ 3,700,000
Granted (in shares)		165,174
Options under the Employee Stock Option Plan
Class of Stock [Line Items]
Weighted-average incremental shares of common stock excluded from the computation (in shares)					27,484
Options under the Employee Stock Option Plan | Operating Partnership Performance Units
Class of Stock [Line Items]
Nonvested shares (in shares)					4,042,993			4,042,993
Options under the Employee Stock Option Plan | Non-vested Stock Award
Class of Stock [Line Items]
Nonvested shares (in shares)					442,263			442,263
Common Stock
Class of Stock [Line Items]
Amount remaining available for issuance under the new ATM | $					$ 750,000,000			$ 750,000,000

Stockholders' Equity - Computat

Stockholders' Equity - Computation of Basic and Diluted Earnings (Loss) Per Common Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Weighted average common shares outstanding
Weighted average common shares outstanding (in shares)	380,829,011	151,620,897	380,812,981	151,230,064
Non-vested shares (in shares)	(1,932,334)	(1,945,042)	(1,952,350)	(1,908,652)
Weighted average common shares outstanding - basic (in shares)	378,896,677	149,675,855	378,860,631	149,321,412
Dilutive effect of employee stock purchase plan (in shares)	0	62,694	0	75,394
Weighted average common shares outstanding - diluted (in shares)	378,896,677	149,738,549	378,860,631	149,396,806
Net (loss) income attributable to common stockholders	$ (82,759)	$ 6,130	$ (169,884)	$ 48,357
Dividends paid on nonvested share-based awards	(588)	(601)	(1,193)	(1,207)
Net (loss) income applicable to common stockholders - basic	$ (83,347)	$ 5,529	$ (171,077)	$ 47,150
Basic earnings per common share - net income (in dollars per share)	$ (0.22)	$ 0.04	$ (0.45)	$ 0.32
Diluted earnings per common share- net income (in dollars per share)	$ (0.22)	$ 0.04	$ (0.45)	$ 0.32

Stockholders' Equity - Summary

Stockholders' Equity - Summary of Activity under Stock-Based Incentive Plans and Restricted Stock Unit (Details) - $ / shares	3 Months Ended			6 Months Ended
	Jun. 30, 2023	Mar. 31, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Restricted Stock Units (RSUs)
Summary of the activity under the incentive plans
Share-based awards, beginning of period (in shares)	363,250	294,932		294,932
Granted (in shares)	0			165,174
Vested/Forfeited (in shares)	0			(17,606)
Probability adjustment of 2022 RSUs (in shares)	0			(79,250)
Share-based awards, ending of period (in shares)	363,250	363,250		363,250
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value [Abstract]
Share-based awards, beginning of period, Weighted average grant date fair value (in dollar per share)	$ 28.57	$ 33.04		$ 33.04
Granted, Weighted average grant date fair value (in dollar per share)	0			22.55
Vested/Forfeited, Weighted average grant date fair value (in dollar per share)	0			33.04
Probability adjustment, Weighted average grant date fair value (in dollar per share)	0			31.68
Share-based awards, ending of period, Weighted average grant date fair value (in dollar per share)	$ 28.57	$ 28.57		$ 28.57
Stock incentive plan
Summary of the activity under the incentive plans
Share-based awards, beginning of period (in shares)	1,955,445	1,795,128	1,951,551	1,795,128	1,562,028
Granted (in shares)	43,276		26,840	325,816	442,024
Vested/Forfeited (in shares)	(62,640)		(36,682)	(164,360)	(61,047)
Forfeited (net change) (in shares)	(3,860)		0	(24,363)	(1,296)
Share-based awards, ending of period (in shares)	1,932,221	1,955,445	1,941,709	1,932,221	1,941,709

Stockholders' Equity - Schedule

Stockholders' Equity - Schedule of Stock Options, Valuation Assumptions (Details)	Jan. 04, 2023 $ / shares
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Volatility	34%
Expected term	3 years
Risk-free rate	4.42%
Stock price (in dollar per share)	$ 20.21
Operating Partnership Performance Units
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Volatility	34%
Expected term	3 years
Risk-free rate	4.42%
Stock price (in dollar per share)	$ 20.21

Stockholders' Equity - Summar_2

Stockholders' Equity - Summary of Activity under Employee Stock Purchase Plan (Details) - Employee stock purchase plan - shares	3 Months Ended		6 Months Ended
	Jun. 30, 2023	Jun. 30, 2022	Jun. 30, 2023	Jun. 30, 2022
Summary of the Employee Stock Purchase Plan activity
Outstanding and exercisable, beginning of period (in shares)	183,426	427,802	340,976	348,514
Granted (in shares)	0	0	0	255,960
Exercised (in shares)	(1,687)	(1,965)	(4,817)	(12,518)
Forfeited (in shares)	(2,370)	(20,303)	(23,791)	(45,789)
Expired (in shares)	0	0	(132,999)	(140,633)
Outstanding and exercisable, end of period (in shares)	179,369	405,534	179,369	405,534

Stockholders' Equity - Amortiza

Stockholders' Equity - Amortization of Compensation for Nonvested Shares (Details) $ in Millions	Jun. 30, 2023 USD ($)
Equity [Abstract]
2023	$ 7.7
2024	13.3
2025	10.8
2026	8
2027	2.4
2028 and thereafter	0.5
Total	$ 42.7

Fair Value of Financial Instr_3

Fair Value of Financial Instruments (Details) - USD ($) $ in Millions	Jun. 30, 2023	Dec. 31, 2022
CARRYING VALUE
Derivative [Line Items]
Notes and bonds payable	$ 5,340.3	$ 5,351.8
Real estate notes receivable	151.5	99.6
FAIR VALUE
Derivative [Line Items]
Notes and bonds payable	5,107.5	5,149.6
Real estate notes receivable	$ 149	$ 99.6